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1.1  Background of genome engineering  
Genome editing should be a highly precise form of genetic engineering which 
alters an organism's genome as small as a single base pair with no incidental or 
auxiliary modifications; this technique is crucial to the field of synthetic biology, 
which requires such precision in the installation of novel genetic circuits into host 
genomes.  Before delving into the background, precise definitions of genome editing 
are required.  Genome editing is defined as a method that (i) uses a nuclease to 
produce a precisely targeted double-strand break (DSB), (ii) repairs the DSB using 
foreign DNA that produces the desired edit, (iii) is capable of targeting an arbitrary 
locus in the genome and (iv) results in a genome containing no integrated superfluous 
genetic material (e.g. loxP sites, genetic markers) (Alexander et al., 2017).  Nucleases 
serve as the core driving force in genome editing as DSB formation recruits DNA 
repair machinery (Finn et al., 2012) which can be co-opted to insert an artificial 
nucleotide sequence of interest into the desired target locus.  Four types of nucleases 
have been used for genome editing: meganucleases, transcription activator-like 
effector nucleases (TALENs), zinc-finger (ZF) nucleases (ZFNs), and Clustered 
Regularly Interspaced Short Palindromic Repeats (CRISPR)-associated nucleases. 
 For genome engineering there are two foundationally important DNA repair 
pathways: 1) Endogenous homology-directed repair (HDR) and 2) non-homologous 
end joining (NHEJ).  HDR is a high-fidelity mechanism since it makes use of donor 
templates with homologous sequences flanking DSBs in order to repair damaged loci.  
HDR allows for error-free DNA repair, whether using a homologous allele or an 
exogenous DNA fragment as repair template (Pâques and Haber et al., 1999).  By 
contrast, NHEJ is an error-prone repair system, which usually inserts or deletes small 
fragments of DNA at a break site (Guirouilh-Barbat et al., 2004; Moore and Haber et 
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al., 1996).  Hence, NHEJ can be exploited to eliminate gene function by way of frame 
shifts (Liang et al.,1998; Storici and Resnick et al., 2006).  However, for both HDR 
and NHEJ, native recombination efficiency, even in the presence of selection, is 
relatively low for most microbial organisms of interest to metabolic engineering.  
Acknowledging that the endogenous function of homologous recombination (HR) 
includes repairing DSBs in the genome and a vast array of studies has focused on 
improving recombination efficiencies (Choulika et al., 1995; Shi et al., 2013; Storici 
et al., 2003).  Thereby, endonucleases are used to induce DSBs in genome 
engineering.  By introducing DSBs, recombination efficiencies between genomic 
DNA and exogenous linearized DNA can be increased by several orders of magnitude 
in the presence of selection marker (Storici et al., 2003).  
 For this reason, characterizing sequence-specific endonucleases for targeted 
genome engineering has attracted much attention.  Initial studies focused on 
meganucleases or homing endonucleases which were first described in the late 1980s 
as components of self-splicing mitochondrial rDNA introns in Saccharomyces 
cerevisiae (Colleaux et al., 1988).  These nucleases have long recognition sites of 12-
40 base pairs that makes them highly specific cutters (Belfort and Roberts, 1997).  
However, the number of identified sequence-specific meganucleases does not meet 
the requirements needed for precision genome engineering of large genomes 
(Chevalier and Stoddard, 2001; Smith et al., 2006). Additionally, homing 
endonucleases have been shown to tolerate degeneracy in their target sequences (Joshi 
et al., 2011).  In order to program sequence-specificity, and thereby genomic loci for 
targeted DSBs, more recent studies have focused on ZFNs and TALENs (Beumer et 
al., 2006; Bibikova et al., 2002; Gajetal., 2013; Katsuyama et al., 2013; Wood et al., 
2011; Zu et al., 2013).  Here, the modular structure of ZFs have made it possible to 
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make up ZF-array sand purposefully reengineer the DNA-binding specificity of 
individual ZFs to bind to longer DNA sequences with a high degree of specificity 
(Sander et al., 2011; Reyon et al., 2012).  Likewise, TALEs can be customized for 
programming DNA specificity (Bogdanove and Voytas, 2011).  When comparing the 
two, engineered TALENs possess several advantages compared to ZFNs, including 
smaller size, lowered repetitive coding sequence and a greater understanding of their 
structure–function relationship (Bogdanove and Voytas, 2011). 
Simultaneously, the reprogramming and adoption of the CRISPR/Cas 
immunity mechanism for RNA-guided programmable and sequence-specific 
introduction of DSBs has in just a few years propelled the area for precision genome 
engineering (Cong et al., 2013; Jinek et al., 2012; Sander and Joung, 2014).  
 
1.2  Genome editing by CRISPR/Cas9  
The advent of new disruptive precision genome engineering tools has sparked 
the beginning of a new era within biotechnology as well as in basic biosciences since 
the application of CRISPR and CRISPR-associated (Cas) proteins has revolutionized 
the field of genome engineering (Doudna and Charpentier, 2014; Sander and Joung, 
2014; Hsu et al., 2014; Si et al., 2014; Cox et al., 2015;).  Historically, CRISPR was 
first discovered in the E. coli genome as palindromic repeats interspaced with short 
DNA sequences (Ishino et al., 1987).  It has evolved as a primitive immune system in 
prokaryotes with the ability to precisely target and edit any genome (Sorek et al., 
2013; Doudna et al., 2014; Hsu et al., 2014; Mohanraju et al., 2016).  It enables fast 
and reliable genetic manipulation in organisms in which it has been used and it only 
requires two components to work: a guide RNA (gRNA), e.g. under an RNA 
polymerase III promoter, and the nuclear localization tag-fused DNA endonuclease, 
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such as CRISPR-associated protein 9 (Cas9) being the most commonly used (Fig. 1).  
The great advantage of this system is the generation of DSBs in desired locus or loci 
by the action of the endonuclease and editing of single or multiple gene achieved by 
cell native repair system. 
In the naturally occurring system, Cas proteins incorporate foreign DNA 
(protospacer) into a CRISPR array in form of a spacer between identical native 
palindromic repeats.  Subsequently, the CRISPR array is transcribed to CRISPR RNA 
(crRNA) protospacers and the crRNAs hybridize to trans-acting RNAs (tracrRNAs), 
creating a crRNA-tracrRNA hybrid. This hybrid associates with the type-II 
endonuclease Cas9 and the whole complex recognizes and cleaves the foreign DNA, 
creating a DSB.  A 20 bp target complementary sequence within crRNA is required 
for Cas9 activity, localized immediately upstream of the protospacer adjustment motif 
(PAM) which is composed of three nucleotides 5’-NGG-3’ or 5’-CCN-3’ required for 
cutting.  Any genomic loci followed by the 5’-NGG-3’ PAM sequence can be targeted 
for modification.  The engineered CRISPR/Cas9 system utilizes the guide RNA 
(gRNA) composed of fused sequences of crRNA and tracrRNA.  By modifying the 20 
bp of the 5’ end of the gRNA molecule, the system can be used to target any desired 
sequence in the genome for editing (Jinek et al., 2012).  Upon DNA cleavage, the cell 
must repair the DNA break in order to survive.  Introduction of desired sequence 
modifications is then achieved by exogenously supplied donor DNA (repair DNA). 
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Fig. 1. Overview of the yeast genome editing methods by CRISPR/Cas9. A single or double plasmid 
system are used to express the Cas9 endonuclease and guide RNA (s) (gRNA). Alternatively, 
the Cas9 gene is integrated into the yeast genome and the gRNA is delivered on a plasmid. After 
expression, the gRNA locates the target sequence and the endonuclease cleaves the foreign DNA that 
subsequently leads to either NHEJ or HR events. Adapted from Fraczek et al. (2018).  
 
 
 
1.3 Genome engineering in S. cerevisiae    
The budding yeast S. cerevisiae is one of the most intensively used, genetically 
tractable, and also a preferred model organism for studies related to cell cycle, 
functional genomics, ageing, protein interaction, cancer and other critical diseases 
(Fields and Song, 1989; Miller-Fleming et al., 2008; Murakami and Kaeberlein, 2009; 
Spellman et al., 1998).  In S. cerevisiae, many of the above-mentioned studies have 
harnessed the native HR machinery as a preferred error-free DNA repair mechanism 
for manipulating both plasmid-based libraries by homology-directed gap repair and 
genome manipulation (Eckert-Boulet et al., 2012; Ma et al., 1987; Oldenburg et al., 
1997). Though gap repair allows for cost-effective and high fidelity DNA assembly of 
plasmids, the poor control of plasmid copy number in whole cell biocatalysts and the 
need for constant selection pressure often limits their robustness in industrial 
fermentations and therefore applicability (Anthony et al., 2009; Bentley et al., 1990; 
Da Silva and Srikrishnan, 2012; Jones et al., 2000).  Thus, genomic integration of 
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exogenous DNA, with flanking homology arms, by HR is often a preferred strategy in 
S. cerevisiae cell factory prototyping (Kuijpers et al., 2013; Storici et al., 2003).  
Despite the fact that robust HR-based integration of exogenous DNA is efficient in 
yeast, the use of selection markers for validating and maintaining DNA integration 
have often limited the numbers of edits that can be introduced even in auxotrophic 
laboratory strains (Solis-Escalante et al., 2013).  Likewise, there is a limited number 
of dominant markers, which requires extensive recycling of them when targeting 
multiple integration events (Siddiqui et al., 2014; Solis-Escalante et al., 2014).  
Furthermore, it is well-known that recycling selection markers by use of 
endonuclease-induced DSBs can lead to internal recombination between flanking 
homologous repeats and thereby lead to unwanted chromosomal rearrangements 
(Delneri et al., 2000; Solis-Escalante et al., 2014). 
 The first successful genome editing by CRISPR/Cas9 in S. cerevisiae was 
published by DiCarlo et al. (2013).  In the years following his initial work, several 
other systems have been reported.  These systems explored the use of single-vector 
systems (Bao et al., 2015; Ryan et al., 2014), selection by drug resistant markers 
(Ronda et al., 2015; Ryan et al., 2014), artificial crisprRNA (crRNA) arrays (Bao et 
al., 2015; Ronda et al., 2015; Ryan et al., 2014), integrating Cas9 into the genome 
(Horwitz et al., 2015), altering expression of the gRNA (Ryan et al., 2014), 
multiplexed editing using gap repair to assemble multiple gRNAs into a single 
plasmid (Horwitz et al., 2015) and synthesizing gRNAs with appropriate repair 
templates using ultralong oligonucleotides (Garst et al., 2016). 
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1.4  gRNA expression strategies in yeast 
Over the last few years, several different approaches have been reported to 
delete genes or integrate DNA sequences into genome in various yeast backgrounds 
(Horwitz et al., 2015; Jacobs et al., 2014; Schwartz et al., 2016; Vyas et al., 2015). 
They usually involve single or double plasmid systems carrying gRNA and the Cas9 
gene, and/or a donor DNA targeting the desired sequence. Some studies have also 
reported stable integration of the Cas9 gene into the genome while the gRNA was 
expressed from a plasmid (Mans et al., 2015).   
DiCarlo et al. (2013) were the first to report a single gene disruption in a yeast 
(S. cerevisiae) haploid strain by HR using the CRISPR/Cas9 system.  They 
demonstrated that targeted DSBs can increase HR in a constitutively expressing Cas9 
strain by 130-fold when transformed with a double-stranded 90 bp oligonucleotide 
containing the homologous ends to the target sequence and a transient gRNA cassette.  
Approach of their double plasmid system resulted in near 100% recombination of the 
donor DNA and a single gene disruption. 
 A double plasmid system was used for example by Bao et al. (2015) in S. 
cerevisiae to delete CAN1 and ADE2 genes, in which Cas9 and tracrRNA are 
expressed on one plasmid and CRISPR array on the another.  The efficiency was only 
14.7% and 12.5% for CAN1 and ADE2, respectively. Changing the strategy to a single 
plasmid system improved the knock‐out efficiency to 100% for both genes.  On the 
other hand, a two‐plasmid system can provide an engineering efficiency of 85-100% 
in a haploid strain by simultaneously introducing three exogenous genes into separate 
loci (Ronda et al., 2015). 
 A similar strategy to the one reported by DiCarlo et al. (2013), using the single 
gRNA expression system (Fig. 2) in a haploid strain and a 90 bp donor DNA, was 
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used by Jakočiūnas et al. (2015) to engineer a promoter region of a gene and delete 
four other genes in S. cerevisiae involved in the production of mevalonate, a key  
 
 
Fig. 2. Diagram of the CRISPR/Cas9 constructs according to DiCarlo et al. (2013).  Adapted from 
Jakočiūnas et al. (2015a).  
 
 
precursor for industrially important isoprenoid production.  High transformation 
efficiency was reported, although no obvious phenotype for single knock-out mutants 
was observed.  They also generated plasmids with one to five gRNAs (single plasmid 
strategy) to simultaneously knock out five genes with efficiency of 50-100% (called 
multiplex CRISPR). 
 Ryan et al. (2014) generated a plasmid (single plasmid system) carrying the 
Cas9 gene and three different gRNA expression cassettes and performed triple gene 
deletions in S. cerevisiae using a multiplex CRISPR (or CRISPRm) approach.  The 
efficiency was only 19% in the diploid strain but near 100% in the haploid.  Using a 
similar methodology to that for the gene knock-out, they assembled in vivo three 
overlapping DNA fragments carrying nourseothricin-resistance marker and integrated 
them into the URA3 locus.  The efficiency was 85% in a diploid strain and 70% in a 
polyploid strain.  Lower efficiency of 15-60% by knocking out four genes one by one 
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(URA3, HIS3, LEU2 and TRP1) in an industrial polyploid strain was reported by 
Zhang et al. (2014). 
 A single plasmid carrying the Cas9 gene and multiple gRNAs was also used 
by Generoso et al., (2016) in S. cerevisiae, which enabled simultaneous deletion of 
multiple genes in haploid and diploid backgrounds. Plasmids were either constructed 
in vitro or assembled in vivo using yeast HR systems.  Around 90% deletion 
efficiency was reported using the in vitro generated plasmids for one to three loci 
deleted at once in the haploid backgrounds and one to two loci in the diploid 
background.  However, the transformation efficiency for the in vivo assembled 
plasmid in both backgrounds was from 0 to 60%. 
 In summary, several different strategies have been adopted for expression of 
both Cas9 and gRNA (Table 1).  From this it is evident that gRNA and Cas9 
expression can be controlled by various means.  Although several genome-
engineering strategies using CRISPR/Cas9 have been described, still it needs critical 
attention to the experimental set-up of interest.  This includes an evaluation of 
parameters like number of genomic edits needed, expression way of gRNA, genetic 
background of the host, and ploidy level. 
 
Table 1: Cas9 and gRNA expression strategies. 
First plasmid/integration Second plasmid Ploidy Engineering 
efficiency 
Study 
pTEF1-Cas9-tCYC1, CEN/ARS pSNR52-gRNA-tSUP4, 2μ n 100% DiCarlo et al ( 
2013) 
pADH1-Cas9-tADH1, 2μ pADH1-HH-gRNA-HDV-
tADH1, CEN/ARS 
n 100% Gao and Zhao 
(2014) 
pTDH3-Cas9-tCYC1 N/A n/2n 19–100% Ryan et al. 
(2014) pTEF1-Cas9-tCYC1 
pRNR2-Cas9-tCYC1 
pREV1-Cas9-tCYC1 
pSNR6-HDV-gRNA-tSNR52 
pSCR1-HDV-gRNA-tSNR52 
pRPR1-HDV-gRNA-tSNR52 
pSNR52-HDV-gRNA-tSNR52 
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ptRNATyr-HDV-gRNA-tSNR52 
ptRNAPro-HDV-gRNA-tSNR52, 
2μ 
pTEF1-Cas9-tADH2, pSNR52-DR-TDR-crRNA-
DR-tSUP4, 2μ, or N/A 
n 13–100% Bao et al. 
(2015) pRPR1-tracrRNA-tRPR1, 
CEN/ARS, or plus pSNR52-DR-
TDR-crRNA-DR-tSUP4 
pTEF1-Cas9-tCYC1, CEN/ARS pSNR52-gRNA-tSUP4, 2μ 2n 15–60% Zhang et al. 
(2014) 
pTEF1-Cas9-tCYC1, CEN/ARS pSNR52-gRNA-tSUP4, 2μ n 50–100% Jakočiūnas et 
al. (2015a) 
pTEF1-Cas9-tCYC1, CEN/ARS pSNR52-gRNA-tSUP4, 2μ 2n 81–97% Stovicek et al. 
(2015) 
GRE3::pFBA1-Cas9-tCYC1 pSNR52-gRNA-tSUP4, 2μ n 2–91% Horwitz et al. 
(2015) 
pTEF1-Cas9-tCYC1, CEN/ARS pSNR52-gRNA-tSUP4, 2μ n 25–100% Mans et al. 
(2015) 
pTEF1-Cas9-tCYC1, CEN/ARS pSNR52-gRNA-tSUP4, 2μ n 25–100% Tsai et al. 
(2015) 
pTEF1-Cas9-tCYC1, CEN/ARS pSNR52-gRNA-tSUP4, 2μ n 31–97% Jakočiūnas et 
al. (2015b) 
pTEF1-Cas9-tCYC1, CEN/ARS pSNR52-gRNA-tSUP4, 2μ n 85–100% Ronda et al. 
(2015) 
(Reference: Jakočiūnas, T.: Metabolic Engineering, 2016) 
 
 
1.5  Objective of this study 
  
For the CRISPR/Cas9 system, guide RNAs (gRNAs) direct the plasmid-
expressed Cas endonuclease to introduce a DSB at a specific genome site, which is 
then repaired by the cellular repair machinery.  The genome can be edited during the 
repair process, depending on the gRNA.  To date, several different approaches for 
expressing the gRNAs have been reported.  However, by reviewing various gRNA 
expression and delivery system in Chapter 1, I realized that all methods employ 
plasmid-based gRNA expression system which is laborious and time-consuming since 
it requires cloning of respective target sequence. 
 To overcome these drawbacks, in Chapter 2, I have developed a simpler PCR-
based system for producing the gRNA, which is called the gRNA–Transient 
Expression System (gRNA-TES).  I evaluated its performance by replacing up to 500 
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kb chromosomal region with a small marker gene Candida glabrata LEU2 (CgLEU2) 
in diploid S. cerevisiae.   
For the analysis of genome function, the deletion or replacement of desired 
chromosomal regions, is very important.  Because of low homologous recombination 
activity even in S. cerevisiae host, however, current methods are limited to 
manipulation of only one chromosomal region in a single transformation, making the 
simultaneous deletion or replacement of multiple chromosomal regions difficult. 
Therefore, in Chapter 3, I developed two highly efficient and versatile genome 
engineering technologies by integrating the CRISPR/Cas9 genome editing system 
with our PCD (PCR-mediated chromosomal deletion) and PCRep (PCR-mediated 
chromosomal replacement) technology, named CRISPR-PCD for simultaneous 
chromosomal deletion and CRISPR-PCRep for simultaneous chromosomal 
replacement in S. cerevisiae.  In CRISPR-PCD, two new split chromosomes are 
generated after the deletion of a specific chromosomal region and in CRISPR-PCRep 
the resultant chromosome is not split, but instead behaves as a single independent 
chromosome.  The summary of all results obtained in this study is described in 
Chapter 4.  Finally, I conclude that these novel genome engineering technologies will 
provide powerful tools to facilitate genome manipulation by greatly reducing time and 
labor, enabling the rapid analysis of genome function and breeding of useful industrial 
yeast strains. 
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Chapter 2 
gRNA-transient expression system for simplified 
gRNA delivery in CRISPR/Cas9 genome editing 
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2.1  Introduction 
 The ability to edit the genome is essential for many state-of-the-art 
experimental methods.  Genome editing by CRISPR/Cas9 system has been shown to 
be functional in S. cerevisiae (DiCarlo et al., 2013).  In the CRISPR/Cas9 system for 
yeast genome engineering, guide RNAs (gRNAs) direct the plasmid-expressed Cas 
endonuclease to introduce a DSB at a specific genome site, which is then repaired by 
the cellular repair machinery.  Depending on the gRNA, the genome can be edited 
during the repair process.   
To date, various strategies for expressing the gRNAs have been developed.  In 
most methods developed for yeast, gRNA components are expressed from a DNA 
cassette (DiCarlo et al., 2013; Ryan et al., 2014; Jakociunas et al., 2015).  For 
example, DiCarlo et al. (2013) identified an effective yeast RNA polymerase III 
promoter and terminator pair (SNR52p and SUP4t) for driving gRNA expression and 
used them in place of the mammalian U6 promoter cassette.  Their design achieved 
nearly 100% marker-less integration at a target locus when the appropriate donor 
DNA was included.  Yeast RNA polymerase II promoters can also drive expression of 
gRNA constructs that are fused to a ribozyme that can cleave the interfering 30 UTR 
(untranslated region) sequence (Ryan et al., 2014).  Using this method, Ryan et al. 
(2014) increased the level of gRNA expression, leading to a higher rate of integration 
of linear DNA modules.  In addition, Bao et al. reported highly efficient gRNA 
expression in yeast via using the natural, two-component crisprRNA (crRNA) and 
trans-activating crRNA (tracrRNA) format (Bao et al., 2015).  With respect to gRNA 
delivery, these multi-step methods result in similarly high engineering efficacy.   
More recently, Horwitz et al. reported an efficient technique in which yeast’s 
ability to repair gaps was used to construct a gRNA-expressing vector inside the yeast 
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cell (Horwitz et al., 2015). In their approach, linear DNA fragments bearing an origin 
of replication and a selectable marker cassette were co-transformed with multiple 
DNA fragments containing gRNA cassettes with short flanking regions sharing 
homology with the linear vector plasmid.  Proper recombination in vivo then 
reconstituted a functional circular vector within the host cell.  In addition, Hao et al. 
synthesized a 114-bp crRNA component containing two gRNAs and partial direct 
repeats, which was digested by BsaI, and then cloned into the pCRCT plasmid for 
gRNA expression (Hao et al., 2016).  By contrast, Sasano, Y. et al. constructed a 
gRNA expression plasmid to target a specific genomic locus by the SLIC (Sequence- 
and Ligation-Independent Cloning) technique with some modifications (Sasano et al., 
2016; Li and Elledge, 2012).   
However, all of the above-mentioned methods are plasmid-based.  Constructing 
plasmids for expressing gRNA can be laborious, costly, and time-consuming.  To 
overcome these drawbacks, I have developed a simpler PCR-based system for 
producing the gRNA, which is called gRNA-TES. In the present study, the gRNA-
TES procedure and its performance is evaluated.  The results of our analysis show that 
gRNA-TES technology is efficient and is completed within 5–6 hours, including the 
transformation process. It therefore facilitates easy, rapid, and effective genome 
engineering, which will be beneficial to scientists applying the CRISPR/Cas9 system 
in the yeast genome. 
 
2.2  Materials and Methods  
2.2.1  Strains, plasmids, primers, and media     
The strains and plasmids used in Chapter 2 are listed in Table 2.  Strain 
SJY344 was constructed as follows: S. cerevisiae strain SJY270 was cultivated in 
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YPDA (2% peptone, 2% glucose, 1% yeast extract and 0.004% adenine sulfate) 
without selection pressure for plasmid maintenance and then plated on YPDA plate 
after appropriate dilution.  Colonies appeared were replica-plated on to -Leu, -His, 
and YPDA plate.  I found colonies showing Leu- and His- at frequency of 
approximately 10% which cannot grow on -Leu and -His plate but can grow on 
YPDA plate.  One of such clones (Leu- His-) were selected and named SJY344.  
Strains SJY347 (Trp+ transformant of SJY344 with p414-TEF1p-Cas9-CYC1t 
(http://www.addgene.org)) (DiCarlo et al., 2013), and SJY344 were used as host 
strains for the gRNA-TES experiment.  For liquid cultivation, yeast strains were 
grown at 30˚C in YPDA medium.  Synthetic complete (SC) medium (0.67% yeast 
nitrogen base without amino acids [Difco, Sparks, MD, USA], 0.2% drop out mix for 
each amino acid or nucleic acid base, and 2% glucose) lacking specific amino acids 
was used to select transformants and to examine auxotrophic phenotype.  For plate 
assays, 2% agar was added to solidify the medium.   
      I used a loxP site-deleted plasmid pSJ69 derived from p3008 (Sugiyama et al., 
2005) to avoid undesired site-specific recombination that might delete loxP-flanked 
chromosomal DNA sequences.  pSJ69 was constructed as follows: p3008 was 
digested with SalI and EcoRV, and the larger fragment was purified by agarose gel 
electrophoresis.  Separately, a CgLEU2 fragment was prepared by PCR using p3008 
as a template, and SJP430 (5’-
TACGCTGCAGGTCGACCAATTCTGTGTTTCCCGG-3’) and SJP431 (5’-
ACTAGTGGATCTGATTTACGTAAAGTTCGTTTGCC-3’) as the respective 
forward and reverse primers.  These two fragments were combined by In-Fusion 
cloning (Takara, Shiga, Japan).   pSJ69 was used as the template for all DNA module 
(Fig. 3 and Table 2).   Primers used in chapter 2 are described in Tables S1, S2, and 
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S3.  Plasmid p414-TEF1p-Cas9-CYC1t expressing Streptococcus pyogenes Cas9, and 
plasmid p426-SNR52p-gRNA.CAN1.Y-SUP4t expressing gRNA for the CAN1 gene 
were purchased from the Addgene repository (http://www.addgene.org;  numbers 
43802 and 43803, respectively) (DiCarlo et al., 2013). 
 
Table 2. Strains and plasmids used in Chapter 2. ?
Strain or 
plasmid 
Description Remarks/ 
reference 
Strains   
SJY5 MATa ura3-52 his3Δ200 leu2Δ1 lys2Δ202 
trp1Δ63 
Winston et al. 
(1995) 
SJY6 MATα ura3-52 his3Δ200 leu2Δ1 lys2Δ202 
trp1Δ63 
Winston et al. 
(1995) 
SJY267 Leu+ transformant of SJY5 with pSJ14 (YEp 
+ LEU2) 
This study 
SJY269 His+ transformant of SJY6 with pSJ12 (YEp 
+ HIS3) 
This study 
SJY270 SJY267 x SJY269 This study 
SJY344 His- Leu- clone from SJY270 (Diploid 
between SJY267 and SJY269) 
This study 
SJY347 Trp+ transformant of SJY344 with pSJ30 This study 
Plasmids    
pSJ12 pRS303 (HIS3) + 2 μ DNA origin Sikorski et al. 
(1989) 
pSJ14 pRS305 (LEU2) + 2 μ DNA origin Sikorski et al. 
(1989) 
pSJ30 p414-TEF1p-Cas9-CYC1t (= YCp + 
CEN6/ARSH4 + TRP1) 
DiCarlo et al. 
(2013) 
pSJ32 p426-SNR52-gRNA.CAN1.Y-SUP4t DiCarlo et al. 
(2013) 
pSJ69 loxP site-deleted p3008 Our stock 
p3008 A derivative of pUG6 carrying 
loxP-CgLEU2-loxP 
Sugiyama et al. 
(2005) 
 
2.2.2  Preparation of DNA modules       
DNA modules to replace the target regions were prepared by PCR (Fig. 3).  
Plasmid pSJ69 harboring the selective marker CgLEU2 was used as a common 
template to amplify all donor DNAs using appropriate forward and reverse primers 
(Table S1) depending on the individual PCR experiment.  The forward primer was 
designed as the first 30-bp sequence of the target region using Saccharomyces 
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Genome Database (SGD: www.yeastgenome.org/) and an additional 20-bp sequence 
homologous to the 5’-GGCCGCCAGCTGAAGCTTCG-3’ sequence (nt 7–26) of 
plasmid p3008 (Sugiyama et al., 2005).  The reverse primer was designed as the last 
30-bp reverse sequence of the respective target region using the same database and an 
additional 20-bp reverse sequence homologous to the 5’-
AGGCCACTAGTGGATCTGAT-3’ sequence (nt 1602–1621) of plasmid p3008.  
 
2.2.3  PCR conditions for generating PCR fragments for gRNA-TES       
Two rounds of PCR were used for gRNA-TES.  The first-round PCR 
contained 0.25 μl of Ex Taq DNA polymerase (Takara, Shiga, Japan), 5 μl of 10 x 
buffer for Ex Taq DNA polymerase, 4 μl of 2.5 mM dNTPs, 1.5 μl (15 pmol) of 
forward and reverse primers (Table S2), and 1 μl (approximately 50 ng) of template 
plasmid pSJ32 in a volume of 50 μl.  The PCR conditions were 94 °C for 2 min, 
followed by 30 cycles of 98 °C for 10 seconds, 55 °C for 30 seconds, and an 
extension step at 68 °C for an appropriate time.  First-round PCR products were 
diluted 100-fold and used as a template for the second-round PCR with the same 
reaction mixture in a final volume of 50 μl.  The second-round PCR conditions were 
94 °C for 2 min, followed by 30 cycles of 98 °C for 10 seconds, 58 °C for 30 seconds, 
and an extension step at 68 °C for 3 min.  
 
2.2.4  Yeast transformation       
Yeast transformation was carried out according to Gietz and Schiestl (2007).  
YPDA broth was used for both main and preculture.  For the selection of 
transformants, cells were plated on appropriate SC medium and incubated at 30 °C for 
3-4 days.  
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2.2.5  Yeast colony PCR       
Colony PCR was used to determine whether expected replacement of the 
chromosomal target region had occurred in transformants.  A small amount of cells 
from each colony was suspended in 10 ?l of 0.02 M NaOH solution, heated at 98 °C 
for 10 minutes, and then transferred to ice.  Next, I added 12.5 μl of Prime Star Max 
Premix 2x (Takara, Shiga, Japan); 0.5 μl of genomic DNA; control primers to amplify 
the CNE1 region as an internal control (forward primer, SJP121, 7.5 pmol; reverse 
primer, SJP242, 7.5 pmol; resulting in 670-bp band); and forward primer SJP127 (7.5 
pmol) and the appropriate reverse primer (7.5 pmol) for the targeted chromosomal 
region (Table S3),  resulting in a 1000-bp PCR product if expected replacement of the 
target region had occurred.  Water was added to a final volume of 25 μl.  The PCR 
conditions were 30 cycles of 98 °C for 10 seconds, 55 °C for 5 seconds, and an 
extension step at 72 °C for 5 seconds.  All PCR amplifications were carried out on an 
Astec PC-320 Program Temp Control System (Astec, Fukuoka, Japan). 
 
2.3  Results and Discussion 
2.3.1  Development of a PCR-based gRNA expression system     
To simplify the expression of gRNA in the S. cerevisiae host (diploid strain 
SJY347), I developed a system based on only PCR without plasmid-based cloning.  
Our basic idea was to develop a simple gRNA expression system that expresses 
gRNA from a PCR fragment (called “fragment C”) (Fig. 3A and B).  Fragment C 
comprised the SNR52 promoter, targeted genome sequence as a guiding sequence, and 
gRNA scaffold, and was prepared by overlap PCR using fragments A and B (Fig. 3A).   
First, I prepared fragments A and B in separate PCR reactions.  For 
preparation of fragment A, the forward primer (Fw A in Fig. 3A) i.e., SJP342 was 
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designed to include a 35-nt sequence from part of the SNR52 promoter region (nt 
3855–3889), which comes from the template plasmid p426-SNR52p-gRNA.CAN1.Y-
SUP4t (full sequence available at Addgene repository, 
https://www.addgene.org/43803/sequences/), followed by a 20-nt guiding sequence 
specific to the targeted genome sequence, and a further 23-nt sequence encoding the 
5’ part of the gRNA scaffold from plasmid p426-SNR52p-gRNA.CAN1.Y-SUP4t (nt 
3910 –3932).  The software CRISPRdirect (https://crispr.dbcls.jp/) was used to select 
the correct target sequence for any input DNA sequence.  The 3' end of the DNA 
target sequence contained a protospacer adjacent motif (PAM) sequence (5'-NGG-3').  
The 20 nt upstream of the PAM sequence was the targeting sequence, and the Cas9 
nuclease cleave target sequence was 3 nt upstream of the PAM.  The reverse primer 
sequence (Rv A in Fig. 3A) SJP115 was also taken from the template plasmid (nt 
5001–5020 in reverse sequence) (Table S2). 
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Fig. 3.  Construction and generation of gRNA-expressing PCR fragments and introduction of these 
fragments to replace targeted chromosomal regions.  (A)  The three types of fragment (A, B, and C) 
used for gRNA-TES.  Fragments A and B were prepared by PCR using plasmid pSJ32 (p426-SNR52p-
gRNA.CAN1.Y-SUP4t) as a common template.  Agarose gel electrophoresis image shows the 
generation of fragments A, B, and C by PCR.  M represents markers (Gene Ladder Wide 2, Nippon 
Gene, Toyama, Japan); Lanes 1, 2, and 3 show fragments A (1166 bp), B (604 bp), and C (1740 bp), 
respectively.  (B) Overview of gRNA-TES.  After preparing the gRNA-expressing PCR fragments 
(fragment C left and right to cause DSB for the left and right edge of target chromosomal region to be 
replaced) and DNA module, they were introduced together into an S. cerevisiae strain expressing Cas9 
(SJY347).  Cas9 introduces DSB at both ends of the target site, leading to increased frequency of HR at 
their flanking regions.  The target region is then thought to be efficiently replaced by the DNA module 
(CgLEU2) via HR. 
 
 
 
 
B A 
26 
 
For PCR preparation of fragment B (Fig. 3A), the forward primer (Fw B) 
SJP120 consisted of a 20-nt sequence from plasmid p426-SNR52p-gRNA.CAN1.Y-
SUP4t (nt 3301–3320), and the reverse primer (Rv B) SJP117 consisted of a 30-nt 
sequence from the same plasmid (nt 3855–3884 in reverse sequence).  The 
complementary sequence of these 30 nt in fragment B was the same as the first 30 nt 
of fragment A in order to anneal fragments and fragment B in the second-round 
overlap PCR. 
      Next, to prepare fragment C, an overlap PCR system (Fig. 3A) was adopted to 
incorporate the whole SNR52 promoter region from plasmid p426-SNR52p-
gRNA.CAN1.Y-SUP4t in order to ensure proper and efficient gRNA expression.  A 
100-fold dilution (x1/100) of fragment A was mixed with the same dilution of 
fragment B and used as a template for PCR to generate fragment C with forward 
primer SJP120 (used to generate fragment B) and reverse primer SJP115 (used to 
generate fragment A) (Fig. 3A).  Example results of PCR for the preparation of 
fragments A, B, and C for a test target sequence are shown in Fig. 3A.  Fragments A, 
B, and C were well amplified by PCR, showing the expected size without additional 
bands.  Similar results were obtained for other target sequences (data not shown).    
Although overlap PCR might generate insertion or deletion in fragment C which may 
not cause much influence, I sequenced approximately 800 bp region including the 
junction region between fragment A and fragment B and its flanking region in two 
arbitrarily selected fragment C.  Sequencing was performed in both forward and 
reverse orientation.  5’-TTACATGTACGTTTGAAGTACAACT-3’ and 5’-
TAAGCGTGACATAACTAATTACATG-3’ were used as forward and reverse 
primer, respectively.  The result of sequencing showed that the sequence of the 
junction region and its flanking region was exactly the expected one in these two 
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fragment C.  Therefore, it would be no problem if PCR reaction mixture containing 
fragment C is used directly for yeast transformation without DNA sequencing. 
2.3.2  Optimization of amount of fragment C in transformation       
Because the above experiments showed that the gRNA-TES method works 
well, I next investigated the amount of fragment C needed for optimal performance to 
elaborate this method.  In these experiments, the Chr4-200 region (nt 494271-694270 
on chromosome 4) was taken for replacement under the assumption that the optimal 
amount of fragment C would not differ drastically from other regions.  For this 
optimization experiment, I pooled PCR product from 5 tubes (each has 50 μl PCR-
reaction mixture) and it was subjected to ethanol precipitation and finally dissolved in 
50 μl water.  Then, DNA concentration was measured at 260 nm using 
spectrophotometer.  I found that the concentration of DNA after ethanol precipitation 
was 0.94 μg/μl.  Since I have known from preliminary transformation experiment that 
11?l (= approximately 10 ?g) of fragment C gave us dozens of transformants, I 
decided to use 11 μl of each fragment C (left and right) in this optimization 
experiment (Table 3).   In order to add less amount of fragment C such as 0.5 μg, 2.5 
μg, 5.0 μg, 7.5 μg for each fragment C (left and right) in yeast transformation mixture, 
the DNA solution of 0.94 μg/μl concentration was diluted with appropriate amount of 
water to adjust DNA concentration so that 11 μl of each DNA solution corresponds to 
respective amount of DNA (Table 3).    
 Next,  various amount of fragment C (left and right) was used for yeast 
transformation.  Performance of gRNA-TES using various amounts of the gRNA-
expressing fragment C was compared in terms of the number of transformants 
obtained (Table 3).  Results revealed that as the amount of fragment C is increased, 
the number of transformants seems to increase; however, more than 10 μg of fragment 
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C in total did not result in further rise in transformant numbers.  By contrast, the 
number of transformants was very small without gRNA-TES.  On the basis of these 
findings, I concluded that 10 μg of fragment C (in total) is optimized amount of 
fragment C to achieve the best performance of gRNA-TES.  
However, since this work was originally to provide a new simple method for 
preparing fragment C expressing gRNA, the protocol was set up without measuring 
DNA concentration every time PCR reaction was done.  By this reason, I expressed 
the amount of DNA as “μl” of reaction mixture (footnote for Table 3) but not “μg” 
and always used 11 μl of PCR reaction mixture for other routinely performed yeast 
transformation because I obtained a sufficient number of transformants using such 
amount (11 μl + 11 μl = 22 μl) of PCR reaction mixture containing each left and right 
fragment C.  I suggest that there would be no problem to use PCR reaction mixture 
directly containing fragment C for yeast transformation without purification. 
 
Table 3. Approximate amount of fragment C used in transformation and number of 
transformants obtained. 
Target 
regiona 
Approximate 
amount of 
fragment C  
left, μgb 
Approximate 
amount of 
fragment C  
right, μgb 
Total  
approximate 
amount of 
fragment C, 
μgb 
No. of 
transformants 
(with gRNA) 
No. of 
transformants 
(without 
gRNA) 
 
 
Chr4-200 
 
  
          0.5 0.5      1.0       70 0 
          2.5 2.5      5.0           150 3 
          5.0 5.0          10.0           270 4 
          7.5 7.5          15.0           100 7 
        10.0        10.0          20.0             40 5 
a The coordinate and length of the target region were 494271–694270 and 200 kb, respectively. 
b The total volume of the DNA mixture was 34 μl (transformation mixture, 360 μl): 11 μl for fragment C left, 11 μl 
for fragment C right, and 12 μl for DNA module. 
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2.3.3  Performance of gRNA-TES and upper size limits of replacement by gRNA-
TES      
The performance of gRNA-TES was evaluated by an experiment in which 
150-kb, 200-kb, 300-kb, 400-kb, and 500-kb regions of chromosome 4 were replaced 
by a small-sized DNA module both with gRNA-TES and without gRNA-TES (i.e., 
transformation of the DNA module without fragment C) (Figs. 4A–C and 5A–F), and 
the number of transformants was compared (Table 4). Strain SJY347, which harbors 
the Cas9-expressing plasmid p414-TEF1p-Cas9-CYC1t, was used as the host, and the 
coordinates of the Chr4-150, Chr4-200, Chr4-300, Chr-400, and Chr4-500 regions 
were nt 494271–644270, 494271–694270, 494271–794270, 494271–894270, and 
494271–994270 of chromosome 4, respectively.   
 
 
 
 
 
 
 
 
 
Fig. 4.  Analysis of chromosome alteration by yeast colony PCR.  (A) Principle of colony PCR for 
verification of the integrity of two edges of the target region.  The forward primer SJP238 was used 
with an appropriate reverse primer to generate a 1975-bp band.  (B) Colony PCR to verify replacement 
of the Chr4-150 and Chr4-200 regions.  A common set of primers (SJP121 and SJP242) were used in 
all PCR verification experiments to amplify the 670-bp CNE1 gene on chromosome 1 as an internal 
control.  Primers SJP238 and SJP350 were used for the 150-kb region (lanes 1–6), and SJP238 and 
SJP351 for the 200-kb region (lanes 7–12) in transformants obtained with gRNA-TES.  Lanes 13–18 
represent results from transformants obtained without gRNA-TES.  (C) Colony PCR to verify 
 B 
C 
(Internal control) 
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replacement of the Chr4-300, Chr4-400, and Chr4-500 regions.  Primers SJP238 and SJP364 were used 
for the 300-kb region (lanes 1–3), SJP238 and SJP365 for the 400-kb region (lanes 4–6), and SJP238 
and SJP366 for the 500-kb region (lanes 7–9).  Lanes 10–15 represent results from transformants 
obtained without gRNA-TES. 
 
 
 
           As a starting point, 11 ?l of each fragment C (left and right) was used in the 
yeast transformation mixture.  The frequency of transformants varied by target region; 
considering the Chr4-150 region as an example, average 263 transformants were 
obtained by using gRNA-TES, whereas only 9 transformants were obtained without 
gRNA-TES (Table 4).  Similarly, 287 transformants were obtained by using gRNA-
TES for the Chr4-200 region, whereas only 9 transformants were obtained without 
gRNA-TES.  Thus, the frequency of transformants was much higher when gRNA-
TES was used. These observations indicate that gRNA-TES performs well because a 
higher number of transformants was obtained with the gRNA-TES method than 
without gRNA-TES.  
I also investigated the upper size limit of the chromosomal region that can be 
replaced by the gRNA-TES method.  Again, the diploid strain SJY347 was used as the 
host,  and replacement of an increasing region from 150 kb to 500 kb was attempted.  
The primers were designed to amplify a 1975-bp PCR product when the expected 
replacement occurred (Fig. 4A–C).  The expected 1975-bp band was obtained with a 
frequency of 100% (5/5) for replacement of the 500-kb region by the gRNA-TES 
method (Fig. 4C, lanes 7–9 and Table 4);  by contrast, the expected 1975-bp band was 
not observed for replacement of the 500-kb region without gRNA-TES (Fig. 4C, lanes 
14, 15 and Table 4).  In a control experiment using the strain SJY344 lacking the 
Cas9-expressing plasmid, the expected band was not observed (data not shown).  
These observations indicate that the efficiency of sequence replacement is much 
higher with gRNA-TES than without gRNA-TES (Fig. 4A-C and Table 4).   Taken 
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together, our observations strongly suggest that gRNA-TES works effectively and can 
successfully achieve replacement of 500-kb or possibly even longer genome regions.   
2.3.4  Structural analysis of chromosome alteration by colony PCR 
Even if the number of transformants is increased by gRNA-TES, the method 
will not be useful if the expected replacement does not occur efficiently.  I therefore 
used colony PCR to assess the expected replacement of the Chr4-150, Chr4-200, 
Chr4-300, Chr4-400, and Chr4-500 regions of chromosome 4.  Because the 
replacement DNA module contained the CgLEU2 marker gene, the presence of the 
CgLEU2 marker in the replacement region was detected via analysis of the i) left and 
ii) right edges of the replacement region; and iii) via analysis of the chromosomal 
structure encompassing both edges of the target region.  
 
2.3.4.1  Verification of the left edge of the replacement region.  
To verify the left edge of CgLEU2, several colonies obtained by gRNA-TES 
in the replacement experiment were analyzed by colony PCR using primers (Table 
S3) designed to amplify a product of 1000 bp, as illustrated in Fig. 5A.  Out of 27 
transformants examined, the expected 1000-bp band was observed in all except for 3 
transformants (Fig. 5B and 5C).  We also used colony PCR to analyze transformants 
obtained without the gRNA-TES method (i.e., transformation with only the DNA 
module) (Fig. 5B and 5C).  Among 20 transformants obtained, the expected 1000-bp 
band was observed in only 1.  Therefore, the expected band indicating successful left 
edge replacement (1000 bp) was observed in 89% (24/27) of transformants obtained 
by gRNA-TES, and only 5% (1/20) of transformants obtained without gRNA-TES 
(Table 5).  Collectively, these results of left edge analysis indicated that replacement 
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with CgLEU2 occurred efficiently when the gRNA-TES (fragment C) method was 
used.   
 
2.3.4.2  Verification of the right edge of the replacement region  
To verify the right edge of CgLEU2, a similar colony PCR analysis was 
conducted using primers (Table S3) also designed to amplify a 1000 bp product, as 
illustrated in Fig. 5D-F.  The expected 1000-bp band were seen in 25 out of 27 
transformants obtained (Table 5).  Among 20 transformants obtained without the 
gRNA-TES method, the expected 1000-bp band was observed in only two.  
Collectively, these results of right edge analysis suggested that replacement with 
CgLEU2 also occurred efficiently only when the gRNA-TES method was used.   
 
2.3.4.3  Analysis of the integrity of both edges of the replacement region  
To confirm that the whole of the target sequence was indeed replaced by the 
DNA module containing CgLEU2, a further colony PCR was conducted using primers 
(Table S3) designed to generate a 1975-bp band if the expected replacement had 
occurred.  Among the transformants analyzed, the frequency of the expected band 
(1975 bp) obtained with gRNA-TES for the Chr4-150, Chr4-200, Chr4-300, Chr4-400, 
and Chr4-500 regions was 67%–100% (Table 4).  By contrast, among 20 
transformants obtained without gRNA-TES (i.e., only the DNA module was used), 
the expected 1975-bp band was observed in only one (Fig. 4A-C).  Taking the results 
of the number of transformants, the structural alteration of the left and right 
replacement region (Table 5), and the structure of the whole target region (Table 4) 
altogether, we conclude that gRNA-TES functions efficiently in yeast. 
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2.3.5  Structural analysis of the homologous chromosome in the transformants       
Because a diploid strain was used in this study, the target region is present in both 
homologous chromosomes.  Therefore, gRNA expressed from fragment C allows 
Cas9 to introduce a DSB in both target regions with equal probability.  If the target 
region in both homologous chromosomes is replaced with the DNA module, however, 
the cell will die because this region (150–500 kb) of chromosome 4 contains essential 
genes whose deletion leads to cell death.  To distinguish the presence of a 
chromosome with or without replacement, I used colony PCR to detect a 1500-bp 
region of the target sequence in the homologous chromosome.  I reasoned that if the 
1500-bp region in the homologous chromosome remains, I would observe both the 
1500-bp band and the 1000-bp band (representing the DNA module containing 
CgLEU2 marker) by colony PCR (Fig. 5G).  By contrast, if the homologous 
chromosome in the transformant has a structural alteration that does not lead to cell 
death, I would not observe the 1500-bp band.  
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Table 4. Transformants obtained by gRNA-TES.  
Deletion 
regiona 
Method No. of transformants  
Transformation Average Analyzed Expected 
replacemen1st  2nd 3rd  
Chr4-150 + gRNA-TES      202 300     287 263 6 6 
– gRNA-TES   10     8   9     9 6 1 
Chr4-200 + gRNA-TES      256 257     350 287 6 4 
– gRNA-TES   12     7   8     9 3 0 
Chr4-300 + gRNA-TES   49   42 63    51 5 4 
– gRNA-TES     6     5 12      7 4 0 
Chr4-400 + gRNA-TES   38   39 54    43 5 5 
– gRNA-TES     5     6 11      7 3 0 
Chr4-500 + gRNA-TES   90 119     102  103 5 5 
– gRNA-TES     7     5   5      5 4 0 
a The length of the Chr4-150, Chr4-200, Chr4-300, Chr4-400, and Chr4-500 regions was 150 kb, 200 kb, 300 kb, 400 kb, a
These regions were replaced in the diploid host strain SJY347. The experiment was carried out three times, and the numbe
 
 
 
 
 
35 
 
Table 5. Analysis of the chromosomal structure of transformants by colony PCR. 
Region Method No. of left edge replacement 
transformants 
No. of right edge replacement 
transformants 
Analyzed Replaced (%) Analyzed Replaced (%) 
Chr4-150 + gRNA-TES 6       6 (100) 6 6 (100) 
- gRNA-TES 6  1 (17) 6   1 (17) 
Chr4-200 + gRNA-TES 6  4 (67) 6   5 (83) 
- gRNA-TES 3       0  3        0  
Chr4-300 + gRNA-TES 5  4 (80) 5   4 (80) 
- gRNA-TES 4       0  4        0  
Chr4-400 + gRNA-TES 5       5 (100) 5 5 (100) 
- gRNA-TES 3       0  3   1 (33) 
Chr4-500 + gRNA-TES 5       5 (100) 5 5 (100) 
- gRNA-TES 4       0  4        0  
All + gRNA-TES Total = 27 Total = 24 (89) Total = 27 Total = 25 (92) 
- gRNA-TES Total = 20 Total = 1 (5) Total = 20 Total = 2 (10) 
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Transformants obtained with gRNA-TES and without gRNA-TES for the 
Chr4-150, Chr4-200, Chr4-300, Chr4-400, and Chr4-500 regions were tested by 
colony PCR using appropriate primers (Table S3), and the expected 1500-bp band 
were observed in all transformants examined (Fig. 5H, lanes 1–18; Fig. 5I, lanes 1–
15).  Thus, the frequency of the expected band (1500 bp) was 100% for all regions 
(Table 4).  These results suggest that in the viable diploid transformants one of the 
homologous chromosomes had no replacement of at least this 1500-bp region, 
indicating that gRNA-TES is effective for obtaining viable transformants with 
replacement of the desired targeted region of one chromosome without causing 
unexpected structural alteration of the homologous chromosome in the diploid host.  
 
    
 
 
 
 
 
 
 
 
A B 
C 
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Fig. 5.  Yeast colony PCR for the verification of chromosome alteration.  (A) Principle of colony PCR 
for verification of left edge replacement of the target region by CgLEU2.  Appropriate forward and 
reverse primers (Table S3) were designed to amplify a 1000-bp band denoting the left edge of CgLEU2 
in transformants.  (B) Colony PCR of the Chr4-150 and Chr4-200 regions to verify left edge 
replacement.  It was performed with two sets of primers.  A common set of primers (SJP121 and 
SJP242) were used to amplify the 670-bp CNE1 gene on chromosome 1 as an internal control, and a 
specific set of primers was used for the target region, in this case SJP238 and SJP119.  Lanes 1–12 
D E 
F 
G H 
I 
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represent results from transformants obtained with gRNA-TES.  Lanes 13–18 represent results for 
transformants obtained without gRNA-TES.  (C) Colony PCR of the Chr4-300, Chr4-400, and Chr4-
500 regions to verify left edge replacement.  SJP238 and SJP119 were used as forward and reverse 
primers, respectively.  Lanes 1–9 represent results from transformants obtained with gRNA-TES.  
Lanes 10–15 represent results from transformants obtained without gRNA-TES.  (D)  Principle of 
colony PCR for verification of the right edge replacement of the target region by CgLEU2.  The 
forward primer SJP127 (CgLEU2: 776-800) was used with an appropriate reverse primer designed to 
amplify a 1000-bp band denoting the right edge of CgLEU2.  (E) Colony PCR of the Chr4-150 and 
Chr4-200 regions to verify right edge replacement.  The forward primer SJP127 was used with the 
reverse primers SJP350 for Chr4-150 and SJP351 for Chr4-200.  Lanes 1–12 represent results from 
transformants obtained with gRNA-TES.  Lanes 13–18 represent results from transformants obtained 
without gRNA-TES.  (F) Colony PCR of the Chr4-300, Chr4-400, and Chr4-500 regions to verify right 
edge replacement.  Lanes 1–9 represent results from transformants obtained with gRNA-TES.  Lanes 
10–15 represents results from transformants obtained without gRNA-TES.  (G) Principle of colony 
PCR to verify the presence of homologous chromosomes with and without the replaced target region.  
Forward primer SJP238 was used with reverse primer SJP119 to amplify a 1000-bp band from the left 
edge of CgLEU2, while SJP238 was used with reverse primer SJP245 to generate a 1500-bp band from 
intact homologous chromosome 4.  (H) Colony PCR of the Chr4-150 (lanes 1–6) and Chr4-200 (lanes 
7–12) regions in transformants obtained with gRNA-TES.  Lanes 13–18 represent results from 
transformants obtained without gRNA-TES.  (I) Colony PCR of the Chr4-300 (lanes 1–3), Chr4-400 
(lanes 4–6), and Chr4-500 (lanes 7–9) regions in transformants obtained with gRNA-TES.  Lanes 10–
15 represent transformants obtained without gRNA-TES.  
 
 
2.4  Summary  and conclusion of Chapter 2 
CRISPR/Cas9 system is one of the most powerful tools for genome 
engineering.  However, some of the steps are laborious and thus reduces its usability.  
In this Chapter, I have developed a simplified method, called the guide RNA-
Transient Expression System (gRNA-TES), to deliver gRNA in yeast.  In gRNA-TES, 
a DNA fragment containing the promoter and gRNA is prepared by two simple PCR 
steps and co-transformed with a DNA module into the host strain; all steps including 
PCR steps and yeast transformation are completed within 5–6 hours in a single day, in 
contrast to conventional plasmid-based gRNA delivery systems, which require at least 
3–4 days to construct and verify the gRNA-expressing plasmids.  The performance of 
gRNA-TES was evaluated by the replacement of 150-kb, 200-kb, 300-kb, 400-kb, and 
500-kb regions of yeast chromosome 4 with a DNA module.  Increased numbers of 
transformants with a high frequency of expected replacement of even the 500-kb 
region were obtained with gRNA-TES as compared with transformation without 
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gRNA-TES. In addition, the integrity of the replaced region was verified in 67%–
100% of transformants tested by colony PCR. I believe that gRNA-TES will vastly 
increase the accessibility of CRISPR/Cas9 technology to biologists and 
biotechnologists by offering a simple, fast, and cost-effective tool to deliver gRNA in 
genome engineering.  Furthermore, it might be applied to plant and animal systems if 
appropriate gene promoters are incorporated in the technology. 
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Chapter 3 
CRISPR-PCD and CRISPR-PCRep: two novel 
technologies for simultaneous multiple 
segmental chromosomal deletion/replacement in 
Saccharomyces cerevisiae 
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3.1  Introduction 
Genome engineering technology has become increasingly important for the 
rapid and efficient manipulation of multiple genetic loci or chromosomal regions 
(Sasano et al., 2016).  It offers a powerful means for elucidating chromosome and 
genome function on a large scale.  In fact, this technology has been shown to be an 
innovative tool for manipulating the genome and revealing genome function in 
humans, animals, plants, bacteria (Vassena et al., 2016; Noda et al., 2017; Bortesi et 
al., 2015; Oh et al., 2014), and especially yeasts (DiCarlo et al., 2013; Jakociunas et 
al., 2015; Ryan et al., 2014).  Our laboratory has been interested for a long time in 
genome engineering of S. cerevisiae because this organism represents one of the most 
tractable genetic models for research on eukaryotic molecular and cellular biology 
and genome science (DiCarlo et al., 2013; Botstein et al., 2011; Kang et al., 2015; 
Ryan et al., 2016), and it also widely used for the production of various useful 
compounds such as biofuels and high-value metabolites (Buijs et al., 2013; Turner et 
al., 2016; Lee et al., 2017).   
A novel genome engineering technology in S. cerevisiae called PCR-mediated 
chromosome splitting (PCS) was developed previously in our laboratory (Sugiyama et 
al., 2005) that can be used to split a yeast chromosome at any desired genomic locus 
and generate two novel functional chromosomes by the addition of a centromere and 
telomere seed sequences (Sugiyama et al., 2009). Subsequently, various chromosome 
engineering technologies have been developed on the basis of PCS, including PCD 
(Sugiyama et al., 2008; Murakami et al., 2007), which is used to delete target 
chromosomal regions; PCR-mediated chromosome duplication (PCDup) (Natesuntorn 
et al., 2015), which can generate segmental aneuploidy at any desired chromosomal 
region; and genome reorganization (GReO) (Ueda et al., 2012), which is a new yeast 
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breeding technology that creates cells harboring a variety of artificial genome 
structure.   
Recently, three genes encoding the human HLA class II β-chain were knocked 
out simultaneously in the same chromosome via CRISPR/Cas9 genome editing 
technology, a system that induces DSBs at any desired site on the chromosome 
(Crivello et al., 2019).  Similarly, two genes located on two separate chromosomes 
were deleted simultaneously in the yeast Saccharomyces pastorianus by Gorter et al. 
(2017).  Simultaneous triple gene knock-out in different chromosomes in S. cerevisiae 
has also been reported by Ryan et al. (2014) and Bao et al. (2015), who used 
CRISPRm and HI-CRISPR (Homology-Integrated CRISPR), respectively.  In 
addition, Lian et al. (2018) knocked out quadruple genes in polyploid industrial yeast 
strains in a single transformation, and quintuple and sextuple gene deletion was 
performed in a single transformation in S. cerevisiae by Jakociunas et al. (2015) and 
Mans et al. (2018), respectively, using CRISPR/Cas9.  Notably, however, all of these 
multiple knockouts are limited to small genes, and the simultaneous deletion of 
multiple wider chromosomal regions in a single transformation has not yet been 
reported either in yeast or in other organisms. 
The aim of this study is therefore to develop genome engineering technology 
for the simultaneous deletion/replacement of multiple (double, triple, quadruple, and 
so on) segmental chromosomal regions in S. cerevisiae.  Building on our previous 
study, in which CRISPR-PCS was established, a combination of CRISPR/Cas9 and 
PCS, to carry out simultaneous and multiple chromosome splitting (Sasano et al., 
2016), I first incorporated the CRISPR/Cas9 system into PCD technology.  PCD is 
very effective for deleting single, but not multiple chromosomal regions in a one-step 
transformation.  Because its efficiency depends on HR, and it is well known that 
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DSBs promote HR, I considered that improving HR activity by integration of the 
CRISPR/Cas9 system would facilitate simultaneous multiple chromosomal deletion.  
The resulting method, which is called CRISPR-PCD, generates two new split 
chromosomes after the deletion of a specific internal chromosomal region.  
For the simultaneous replacement of multiple segmental chromosomal 
regions, I initially developed the method of PCRep, in which a particular 
chromosomal region is replaced by donor DNA carrying selective marker such as 
CgLEU2, CgHIS3 (C. glabrata HIS3), or ScURA3 (S. cerevisiae URA3).  In PCRep, 
the resultant chromosome is not split as in PCD (at internal region), but instead 
behaves as a single independent chromosome.  Then I integrated CRISPR/Cas9 
technology into PCRep to establish CRISPR-PCRep.  I believe that two methods, 
CRISPR-PCD and CRISPR-PCRep, together represent a powerful tool not only for 
rapid investigations of genome function but also for industrial applications of S. 
cerevisiae. 
 
3.2  Materials and Methods  
3.2.1  Strain, plasmids, and media  
The strain and plasmids used in Chapter 3 are listed in Table 6.  S. cerevisiae 
strain SJY6 (Winston et al., 1995) harboring a plasmid expressing Cas9 (p414-
TEF1p-Cas9-CYC1t) was named FY834-Cas9 and used as the host strain for the 
CRISPR-PCD and CRISPR-PCRep experiments.  E. coli DH5α was used for plasmid 
construction and propagation; E. coli cells were grown in Luria-Bertani (LB) medium 
containing 100 μg/ml of ampicillin. Yeast cells were grown in YPDA medium or SC 
medium (See Chapter 2). SC medium lacking specific amino acid(s) was used for 
auxotrophic marker selection and phenotypic analysis.   
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Table 6. Strain and plasmids used in Chapter 3. 
Strain/Plasmid Genotype/Description 
 
Remarks/Reference 
SJY6 MATα ura3-52 his3-Δ200 leu2Δ1 lys2Δ202 
trp1Δ63 
Winston et al. 
(1995) 
FY834-Cas9 Trp+ transformant of SJY6 Our stock 
p3008 
 
The loxP-CgLEU2-loxP module-containing 
plasmid constructed by modifying pUG6 
Sugiyama et al. 
(2005) 
p3009 The loxP-CgHIS3-loxP module-containing 
plasmid constructed by modifying pUG6 
Sugiyama et al. 
(2005) 
p3121 The CEN4 module-containing plasmid 
constructed by modifying pUG6 
Sugiyama et al. 
(2005) 
pSJ23 A derivative of pUG6 carrying URA3 gene Our stock 
pSJ69 loxP site-deleted p3008 Easmin et al. 
(2019) 
pSJ70 loxP site-deleted p3009 Our stock 
p414-TEF1p-
Cas9-CYC1t  
TEF1p-Cas9-CYC1t module-containing YCp-
type plasmid 
DiCarlo et al. 
(2013) 
p426-SNR52p-
gRNA.CAN1.Y-
SUP4t 
SNR52p-gRNA.CAN1.Y-SUP4t module-
containing YEp-type plasmid 
DiCarlo et al. 
(2013) 
 
 
3.2.2  Yeast Transformation 
The transformation method was the same as in Chapter 2 (2.2.4). 
 
3.2.3  Expression of gRNA 
Plasmids expressing a gRNA to target a specific genomic locus were 
constructed either by the SLIC technique (Li et al., 2012) with modifications (Sasano 
et al., 2017) or by the gRNA-TES (Chapter 2) technique, which facilitates the 
expression of gRNA from PCR fragments (Easmin et al., 2019).  I searched for the 
PAM sequence for Cas9 cleavage (5’-NGG-3’ or 5’-CCN-3’) by using the software 
CRISPRdirect (https://crispr.dbcls.jp/), and the target sequence was designed to lie 
inside the region to be deleted so that Cas9 would not cause further DSBs after the 
45 
 
deletion.  The gRNA targeting sequences are listed in Table S4.  The optimum 
amount (7.5 μg) of gRNA expression plasmid (Sasano et al., 2016) was used for 
efficient transformation and deletion in CRISPR-PCD, whereas 4.0 - 5.0 μg of gRNA-
expressing PCR fragments was used for efficient replacement of the targeted 
chromosomal region in CRISPR-PCRep.  The primers used for construction of the 
gRNA expression plasmid and for generating gRNA expressing PCR fragments are 
listed in Table S5.    
 
3.2.4  Construction of DNA modules needed for deletion by CRISPR-PCD or 
replacement by CRISPR-PCRep 
Two deletion modules (each carrying 50 bp of homologous sequence) were 
needed for the CRISPR-PCD method.  Each of the resulting new chromosomes was 
designed to possess one centromere. Therefore, the modules contained either a 
centromere (CEN4) or a selective marker (CgHIS3 or CgLEU2), in addition to a 
telomere seed sequence (six copies of 5’-CCCCAA-3’).  Plasmid p3121 was used as a 
template to add the CEN4 sequence to the module.  Plasmid p3008 or p3009 was used 
as a template for PCR using the CA primer (reverse primer) to add the telomere seed 
sequence and appropriate forward primer to prepare the deletion module containing 
CgHIS3 or CgLEU2, respectively.  Alternatively, in the CRISPR-PCRep method, a 
donor DNA module (carrying 50 bp of homologous sequence) containing CgLEU2, 
CgHIS3, or ScURA3 was prepared using plasmid pSJ69, pSJ70, or pSJ23, 
respectively.  All primers used for the construction of deletion module and donor 
DNA module are listed in Table S5.  The chromosomal regions targeted for deletion, 
their size, and the plasmids used to prepare deletion modules are described in Table 
S6. 
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3.2.5  Pulsed-field gel electrophoresis and Southern blot hybridization 
Chromosomal DNAs from S. cerevisiae cultured in YPDA medium were 
embedded in agarose plugs as described by Sheehan and Weiss (1990). Chromosomes 
were separated by a CHEF-DR® III pulsed-field gel electrophoresis (PFGE) system 
(Bio-Rad) on a 1% gel in 0.5 x TBE (Tris-borate-EDTA) buffer at 14°C. After 
ethidium bromide staining, DNA was transferred onto a HybondTM-N+ membrane 
(GE Healthcare) by capillary blotting. Probe labeling, hybridization, and signal 
detection were carried out by using an ECL DirectTM nucleic acid labeling and 
detection system (GE Healthcare).  The oligonucleotide primers used for amplifying 
the DNA fragments for Southern hybridization probes are listed in Table S5. 
 
3.3  Results and Discussion 
3.3.1  Concept of CRISPR-PCD and CRISPR-PCRep 
To obtain simultaneous and multiple deletions of desired chromosomal 
regions, I combined CRISPR/Cas9 and PCD technology (Fig. 6).  In this approach, 
two deletion modules are introduced into a yeast cell together with two gRNA 
plasmids to obtain a deletion strain.  As a result of deletion of the targeted region, two 
new split chromosomes are generated in the transformants (Fig. 6A).  Alternatively, to 
replace multiple chromosomal regions simultaneously, I combined CRISPR/Cas9 and 
PCRep technology. In this approach, a donor DNA module containing a CgLEU2, 
CgHIS3, or ScURA3 marker gene is introduced into a yeast cell, together with two 
PCR fragments expressing gRNAs.  After transformation, the resultant chromosome 
remains as a single independent chromosome because the targeted chromosomal 
region is simply replaced by the donor DNA module (Fig. 6B).    
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Fig. 6.  Concept of CRISPR-PCD and CRISPR-PCRep.  (A) Outline of CRISPR-PCD.  Two plasmids 
expressing a 20-bp gRNA specific for the target site and two deletion modules per target site are 
transformed into the FY834-Cas9 strain, which harbors a Cas9-expressing plasmid.  For a segmental 
chromosomal region deletion, one deletion module contains a selective marker (CgLEU2 or CgHIS3), 
while the other contains CEN4 as a centromere.  In transformed cells, DSBs are induced near the target 
site by CRISPR/Cas9, and the specific chromosomal region is deleted by CRISPR-PCD.  After 
transformation, expected transformants are selected via the marker carried on the deletion modules.  No 
selection of the gRNA-expressing plasmid is needed.  Closed black and red circles represent the native 
centromere and CEN4, respectively.  Green box represents selective marker gene.  Pink and violet 
boxes represent the homologous sequences for recombination. Arrows indicate the telomere sequence.  
(B) Outline of CRISPR-PCRep.  To replace a specific segmental chromosomal region, two PCR 
fragments expressing gRNAs specific for the target site and one donor DNA module per target site are 
transformed into the host strain FY834-Cas9.  DSBs are induced at both ends of the target site by 
CRISPR/Cas9, leading to increased frequency of HR at their flanking regions.  The targeted 
chromosomal region is then efficiently replaced by the donor DNA module via HR.  After 
transformation, expected transformants are selected by a selective marker (e.g., CgLEU2, CgHIS3, or 
ScURA3) on the donor DNA module.  Here, CgLEU2 is shown as an example.   
 
3.3.2  Increased frequency of transformants by CRISPR-PCD  
To assess the performance of CRISPR-PCD, I first attempted to delete the 22-
kb of left-terminal region of chromosome 8 (Chr. 8-L) (Fig. 7A).  The FY834-Cas9 
strain was transformed by the simultaneous introduction of deletion modules marked 
A B 
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with the LEU2 gene (CgLEU2) for the Chr. 8-L region and the gRNA expression 
plasmid p426-C8-L (Table S4), whose target sequence was located at position 
22165.5 on Chr. 8 (Saccharomyces Genome Database: 
https://www.yeastgenome.org/).  A total of 1822 Leu+ transformants were obtained 
with the CRISPR-PCD system.  By contrast, under the same transformation 
conditions except that no gRNA expression plasmid was added (i.e., only the DNA 
modules were used), the conventional PCD method yielded only 8 Leu+ transformants 
(Table 7 and Fig. 7B). Thus, the frequency of transformants was improved 228-fold 
by the CRISPR-PCD method relative to conventional PCD.  I chose 10 CRISPR-PCD 
transformants at random and analyzed structural alterations of the chromosomes by 
colony PCR to determine whether the deletion event had occurred at the expected 
locus (Fig. 7C). The analysis showed that the terminal region of Chr. 8-L (22 kb) was 
deleted in all transformants. I also attempted to delete Chr. 11-L (30 kb) obtaining 
1326 transformants by CRISPR-PCD and 48 transformants by conventional PCD.  
Among 14 CRISPR-PCD transformants examined, 13 had the expected terminal 
deletion (Table 7).   
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Fig. 7. Analysis of transformants obtained from segmental deletion by colony PCR.  (A)  Scheme for 
deletion of Chr. 8-L (22 kb) and Chr. 11-L (30 kb).  The primers for colony PCR target the deletion 
region; thus, the band will disappear if the deletion takes place.  (B) Colony PCR analysis of 
transformants obtained by conventional PCD. Among 8 transformants analyzed for Chr. 8-L, 2 showed 
the expected deletion because the 647-bp band disappeared (lanes 1 and 5).  Among 6 transformants 
analyzed for deletion of Chr. 11-L, all 6 showed the expected deletion because the 992-bp band 
disappeared. (C) Colony PCR analysis of transformants obtained by CRISPR-PCD. All 10 
transformants showed the expected deletion of Chr. 8-L (disappearance of the 647-bp band) and 13 of 
14 transformants showed the expected deletion of Chr. 11-L (disappearance of the 992-bp band).   
 
 
 
 In order to compare the efficiency of CRISPR-PCD with conventional PCD, 
next I attempted to delete the internal regions of Chr. 15-8 (24 kb) and Chr. 15-11 (26 
kb) (Fig. 8A).  I obtained 1808 and 3532 Leu+ transformants for Chr. 15-8 (24 kb) and 
Chr. 15-11 (26 kb), respectively, by CRISPR-PCD, but none by conventional PCD.  I 
A 
C 
B 
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randomly picked 10 CRISPR-PCD transformants and examined the karyotype by 
PFGE followed by Southern hybridization analysis.  Because the hybridization probe 
was targeted to a sequence within each deletion area, no signals should be observed 
by Southern blotting if the targeted region is deleted (Fig. 8B).  The analysis revealed 
that 8 and 10 transformants for the deletion of Chr. 15-8 and Chr. 15-11, respectively, 
showed expected result (Table 7).  Thus, I concluded that the frequency of 
transformants is significantly increased by the CRISPR-PCD method, irrespective of 
the position of the chromosomal deletion (i.e., terminal or internal).   
 
Table 7.  Transformants obtained in segmental chromosomal deletion by CRISPR-
PCD. 
Deleted 
region 
(size) 
Methoda No. of 
transformants 
obtained 
No. of 
transformants 
analyzed by 
karyotyping 
No. (%) of 
transformants 
with expected 
deletion 
Chr. 8-L 
(22 kb) 
CRISPR-PCD 1822 10 10 (100) 
Conventional 
PCD 
      8   8     2 (25) 
Chr. 11-L 
(25 kb) 
CRISPR-PCD 1326 14   13 (93) 
Conventional 
PCD 
    48   6   6 (100) 
Chr. 15-8  
(24 kb) 
CRISPR-PCD 1808 10     7 (70) 
Conventional 
PCD 
      0   -    - 
Chr. 15-11  
(26 kb) 
CRISPR-PCD 3532 10 10 (100) 
Conventional 
PCD 
      0   -    - 
a Method: In this experiment, plasmid-based gRNA expression method was used in CRISPR-PCD, and targeted 
chromosomal region was deleted because of newly generated two chromosome. 
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Fig. 8. Deletion of an internal chromosomal segment by CRISPR-PCD.  (A) Scheme for deletion of 
Chr. 15-8 (24 kb) and Chr. 15-11 (26 kb).  The total length of the chromosome is shown in parentheses.  
The deletion module is marked with CgLEU2.  Segmental deletion results in two chromosomes; for 
example, after deletion of Chr. 15-8 (24 kb), two chromosomes of 567 kb and 500 kb should be 
generated.  (B)  Karyotype analysis of Chr. 15-8 (24 kb) and Chr. 15-11 (26 kb) deletion transformants.  
Left panel, PFGE analysis of wild type FY834-Cas9 (WT) and 10 randomly chosen transformants 
(lanes 1-10) of Chr. 15-8 (24 kb) deletion strain are shown.  After deletion of Chr. 15-8 (24 kb), 567 kb 
and 500 kb were generated.  Among 10 transformants, 8 showed the expected result for deletion of Chr. 
15-8 (lanes 2, and 4-10).  Right panel, PFGE analysis of 10 randomly chosen transformants (lanes 1-
10) of Chr. 15-11 (26 kb) deletion strain and WT are shown.  After deletion of Chr. 15-11 (26 kb), 969 
kb and 96 kb were generated.  Among 10 transformants, all showed the expected result for deletion of 
Chr. 15-11 (lanes 1-10).  
 
 
 
3.3.3  Simultaneous double deletion by CRISPR-PCD and replacement by 
CRISPR-PCRep 
Next, I examined whether CRISPR-PCD could induce simultaneous terminal 
deletion at two genomic loci on different chromosomes, namely, Chr. 8-L (22 kb) and 
Chr. 11-L (30 kb) (Fig. 9A).  Double selection was used for transformation, resulting 
in 1096 Leu+His+ transformants by CRISPR-PCD, but no transformants by 
A 
B 
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conventional PCD (Table 8).  Six CRISPR-PCD transformants were randomly 
selected and analyzed for occurrence of the double deletion by using PFGE and 
Southern blot analysis (Fig. 9B).  Intact Chr. 8 (563 kb) and Chr. 11 (667 kb) was not 
observed in six and one transformants, respectively, of the 6 transformants.  Thus, 
bands at 541 kb and 637 kb appeared, suggesting plausible deletion of the Chr. 8-L 
and Chr. 11-L regions.  To verify these results, I performed colony PCR of other 11 
transformants to analyze deletion of the 22 kb (Chr. 8-L) and 30 kb (Chr. 11-L) 
regions (Fig. 9C).  The primers were designed to target a sequence within the deletion 
area such that a band will not be observed if targeted region is deleted.  The 647-bp 
and 992-bp bands were not seen in 3 of 11 transformants analyzed, indicating 
simultaneous deletion of the Chr. 8-L (22 kb) and Chr. 11-L (30 kb) regions.  These 
results demonstrate that simultaneous double deletion of terminal regions can be 
achieved in a one-step transformation using CRISPR-PCD. 
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Fig. 9.  Simultaneous deletion of two terminal chromosomal regions by CRISPR-PCD.  (A)  Scheme 
for simultaneous deletion of Chr. 8-L (22 kb) and Chr. 11-L (30 kb).  The length of the chromosome is 
shown in parentheses.  The Southern blotting probe targets chromosome 8 (563 kb) and chromosome 
11 (667 kb); thus, bands at 541 kb and 637 kb will appear if the respective Chr. 8-L (22 kb) and Chr. 
11-L (30 kb) regions are deleted. The primer for colony PCR targets the deletion region; thus, the 
bands will disappear if the regions are deleted.  (B) Karyotype analysis of transformants by PFGE and 
Southern blot hybridization.  Among six randomly selected transformants, one showed the expected 
result for simultaneous double deletion (lane 6).  (C)  Colony PCR.  Among 11 transformants analyzed 
by colony PCR, three showed the expected double deletion (lanes 3, 6, and 11). 
B 
C 
A 
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To further evaluate the performance of CRISPR-PCD, I attempted to 
simultaneously delete two internal regions, Chr. 9-5 (22 kb) and Chr. 15-11 (26 kb), 
located on different chromosomes (Fig. 10A).  The deletion of these regions requires 
the simultaneous occurrence of HR at four different sites.  After double selection, 47 
Leu+His+ transformants were obtained by the CRISPR-PCD method, but no 
transformants were obtained by conventional PCD (Table 8).  Among 15 randomly 
selected CRISPR-PCD transformants, 3 were confirmed to have simultaneous double 
deletion by colony PCR analysis (Fig. 10B).   
 
 
Table 8. Transformants obtained after simultaneous double deletion by CRISPR-PCD. 
Deleted region 
(size)a 
Methodb No. of 
transformants 
obtained 
No. of 
transformants 
analyzed 
No. (%) of 
transformants 
with expected 
deletion 
Chr. 8-L (22 kb) 
and Chr. 11-L 
(30 kb) 
CRISPR-PCD        1096 17 4 (23) 
Conventional 
PCD 
     0 - - 
Chr. 9-5 (22 kb) 
and Chr. 15-11 
(26 kb) 
CRISPR-PCD    47 15 3 (20) 
Conventional 
PCD 
     0 - - 
a Chr. 8-L (22 kb) and Chr. 11-L (30 kb) represents simultaneous terminal deletion of two chromosomal 
regions; and Chr. 9-5 (22 kb) and  Chr.15-11 (26 kb) represents simultaneous internal deletion of two 
chromosomal regions.  
b In this experiment, plasmid-based gRNA expression method was used in CRISPR-PCD, and targeted 
chromosomal region was deleted because of newly generated two chromosome. 
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Fig. 10.  Simultaneous deletion of two internal regions by CRISPR-PCD. (A) Scheme for simultaneous 
deletion of Chr. 9-5 (22 kb) and Chr. 15-11 (26 kb).  The primer for colony PCR targets the deletion 
region; thus, the band will disappear if the deletion takes place.  (B) Analysis of transformants obtained 
by CRISPR-PCD by colony PCR.  Among 15 randomly selected transformants, 3 showed the expected 
double deletion (i.e.,  the 465-bp band for Chr. 9-5 and the 387-bp band for Chr. 15-11 disappeared in 
the same transformant) (lanes 6, 7, and 9). 
 
I also examined whether CRISPR-PCRep could induce simultaneous 
replacement of two other chromosomal regions, Chr. 12-2 (14 kb) and Chr. 7-4 (19 
kb).  In this experiment, I employed gRNA-TES (in Chapter 2), instead of using 
plasmid-based method.  Overall, 1450 Leu+His+ transformants were obtained after 
simultaneous double replacement experiment of the Chr. 12-2 and Chr. 7-4 regions 
with a frequency of 100% replacement observed for 6 transformants that were 
randomly picked and analyzed by colony PCR (Table 9 and Fig. 11).  All primers 
used in this Chapter for colony PCR are listed in Table S5.  Chromosomal structural 
B 
A 
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analysis of transformants potentially harboring the double replacement was performed 
by colony PCR.  Left, right, and both edges of each of the two target regions, for 
example Chr. 12-2 and Chr. 7-4, were analyzed to determine whether the regions had 
been replaced by the two DNA modules carrying the selective markers CgLEU2 and 
CgHIS3 (Fig. 11A-D).  Notably, all 6 of the transformants analyzed showed 
simultaneous double replacement (i.e., 100% frequency) (Table 9).  I further 
examined the simultaneous double replacement of internal regions by CRISPR-
PCRep for four pairs of chromosomal regions.  Overall, 1600 (Chr. 4-10 and Chr. 12-
2), 1800 (Chr. 3-2 and Chr. 5-3), 900 (Chr. 3-2 and Chr. 7-4), and 83 (Chr. 4-4 and 
Chr. 5-3) transformants were obtained by using CRISPR-PCRep (Table 9), but no 
transformants were obtained by using conventional PCRep in which only a DNA 
module was used (data not shown).  Thus, I concluded that the simultaneous double 
replacement of internal chromosomal regions can be performed very efficiently by 
CRISPR-PCRep.  
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Fig. 11.  Simultaneous replacement of two internal regions by CRISPR-PCRep.  (A)  Scheme for 
simultaneous replacement of Chr. 12-2 (14 kb) and Chr. 7-4 (19 kb).  Closed black circle represents the 
centromere.  Green and pink boxes represent Chr. 12-2 (14 kb) and Chr. 7-4 (19 kb), respectively.  (B) 
Colony PCR for verification of simultaneous left-edge replacement of Chr. 12-2 (14 kb) and Chr. 7-4 
(19 kb).  The DNA modules for Chr. 12-2 and Chr. 7-4 replacement were marked with CgLEU2 and 
CgHIS3, respectively.  Six transformants were analyzed and transformants in lanes 1-6 correspond to 
those in lanes 7-12.  Appropriate primers were used to amplify 1000-bp (lanes 1-6) and 900-bp (lanes 
7-12) band denoting the left edge of CgLEU2 and CgHIS3, respectively, in transformants.  The 670-bp 
CNE1 gene on chromosome 1 was also amplified as an internal control by a common set of primers.  
All transformants analyzed showed the expected simultaneous left-edge replacement of the two regions.  
(C) Colony PCR for verification of simultaneous right-edge replacement of Chr. 12-2 and Chr. 7-4.  
Appropriate primers were used to amplify 1000-bp (lanes 1-6) and 950-bp (lanes 7-12) bands denoting 
the right edge of CgLEU2 and CgHIS3, respectively, in transformants.  All transformants analyzed 
showed the expected simultaneous right-edge replacement. (D) Colony PCR for verification of 
simultaneous whole-region replacement of the same chromosomal regions.  Appropriate primers were 
used to amplify 1975-bp (lanes 1-6) and 1875-bp (lanes 7-12) bands denoting the presence of CgLEU2 
and CgHIS3, respectively, in transformants.  All transformants analyzed showed the expected (100%) 
double replacement. 
 
A 
B C D 
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Table 9. Transformants obtained in simultaneous double replacements by CRISPR-PCRep. 
a Method: In this experiment, PCR fragment-based gRNA expression method was used in CRISPR- PCRep, and target
donor DNA modules. 
 
  
Replaced region (size)  Methoda No. of transformants 
obtained 
No. of transfo
analyzed by col
Chr. 7-4 (19 kb) and   
Chr. 12-2 (14 kb) 
CRISPR-PCRep 1450 6 
Conventional PCRep       0 - 
Chr. 4-10 (14 kb) and   
Chr. 12-2 (14 kb) 
CRISPR-PCRep 1600 6 
Conventional PCRep       0 - 
Chr. 3-2 (15 kb) and   
Chr. 5-3 (15 kb) 
CRISPR-PCRep 1800 6 
Conventional PCRep       0 - 
Chr. 3-2 (15 kb) and   
Chr. 7-4 (19 kb) 
CRISPR-PCRep   900 6 
Conventional PCRep       0 - 
Chr. 4-4 (24 kb) and   
Chr. 5-3 (15 kb) 
CRISPR-PCRep      83 6 
Conventional PCRep       0 - 
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3.3.4  Simultaneous multiple deletion by CRISPR-PCRep 
To our knowledge, the one-step simultaneous deletion of three internal 
chromosomal regions, on either the same or different chromosomes, has not been 
successful in any previous study; therefore, I attempted to delete three internal 
chromosomal regions via a replacement experiment using CRISPR-PCRep.  First, I 
attempted the simultaneous replacement of four sets of three internal chromosomal 
regions [set 1: Chr. 3-2 (15 kb), Chr. 4-10 (14 kb), and Chr. 9-5 (22 kb); set 2: Chr. 4-
10 (14 kb), Chr. 7-4 (19 kb), and Chr. 12-2 (14 kb); set 3: Chr. 3-2 (15 kb), Chr. 7-4 
(19 kb ), and Chr. 15-11 (26 kb); and set 4: Chr. 3-2 (15 kb), Chr. 4-10 (14 kb), and 
Chr. 7-4 (19 kb)], by one-step transformation.  After triple selection for transformants, 
83, 25, 14, and 7 Leu+ His+ Ura+ transformants were obtained for sets 1, 2, 3, and 4, 
respectively.  By contrast, no transformants were obtained by conventional PCRep for 
any set (Table 10).  Colony PCR analysis of 5 randomly selected CRISPR-PCRep 
transformants from set 1 result revealed that all 5 transformants showed the expected 
simultaneous triple replacement (i.e., 100% frequency) (Fig. 12A-D).   The colony 
PCR results of the chromosomal regions replaced in the other sets revealed that 83% 
(5/6), 100% (5/5), and 100% (4/4) of transformants analyzed from sets 2, 3, and 4, 
respectively, also showed the expected simultaneous replacement (data not shown).  
From these observations, I concluded that the simultaneous triple deletion of internal 
regions via replacement can be performed efficiently by CRISPR-PCRep. 
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FIG. 12.  Simultaneous replacement of three internal regions by CRISPR-PCRep.  (A) Scheme for 
simultaneous triple replacement of Chr. 3-2 (15 kb), Chr. 4-10 (14 kb), and Chr. 9-5 (22 kb).  Blue, 
pink, and green boxes represent Chr. 3-2 (15 kb), Chr. 4-10 (14 kb), and Chr. 9-5 (22 kb), respectively.  
(B) Colony PCR for verification of simultaneous left-edge replacement of Chr. 3-2, Chr. 4-10, and Chr. 
9-5.  The DNA modules for Chr. 3-2, Chr. 4-10, and Chr. 9-5 were marked with CgLEU2, CgHIS3, and 
ScURA3, respectively.  Five transformants were analyzed and transformants in lanes 1-5 correspond to 
those in lanes 6-10 and 11-15.  Appropriate primers were used to amplify 1200-bp (lanes 1-5), 1000-bp 
(lanes 6-10), and 800-bp (lanes 11-15) bands denoting the left edge of CgLEU2, CgHIS3, and ScURA3, 
respectively, in transformants.  The 670-bp CNE1 gene was also amplified as an internal control.  All 
transformants showed the expected simultaneous left-edge replacement of the three regions.  (C) 
Colony PCR for verification of simultaneous right-edge replacement of Chr. 3-2, Chr. 4-10, and  Chr. 
9-5.  Appropriate primers were used to amplify 1200-bp (lanes 1-5), 1000-bp (lanes 6-10), and 800-bp 
(lanes 11-15) bands denoting the right edge of CgLEU2, CgHIS3, and ScURA3, respectively, in 
transformants.  All transformants showed the expected simultaneous right-edge replacement of the 
three regions. (D) Colony PCR for verification of simultaneous whole-region replacement of the same 
chromosomal regions.  Appropriate primers were used to amplify 2400-bp (lanes 1-5), 2000-bp (lanes 
6-10), and 1600-bp (lanes 11-15) bands denoting the presence of CgLEU2, CgHIS3, and ScURA3, 
respectively, in transformants.  All transformants analyzed showed the expected (100%) triple 
replacement. 
 
 
A 
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Table 10. Transformants obtained in simultaneous triple replacements by CRISPR-PCRep. 
a Method: In this experiment, PCR fragment-based gRNA expression method was used in CRISPR-PCRep, and targeted c
donor DNA modules. 
 
  
Replaced region (size) Methoda No. of 
transformants 
obtained 
No. of transf
analyzed
colony P
Chr. 3-2 (15 kb),  Chr. 4-10 (14 kb), 
and Chr. 9-5 (22 kb)  
CRISPR-PCRep               83 5 
Conventional PCRep     0 - 
Chr. 4-10 (14 kb), Chr. 7-4 (19 kb), 
and  Chr. 12-2 (14 kb) 
CRISPR-PCRep   25 6 
Conventional PCRep     0 - 
Chr. 3-2 (15 kb),  Chr. 7-4 (19 kb), 
and   Chr. 15-11 (26 kb) 
CRISPR-PCRep   14 5 
Conventional PCRep     0 - 
Chr. 3-2 (15 kb),  Chr. 4-10 (14 kb), 
and  Chr. 7-4 (19 kb) 
CRISPR-PCRep     7 4 
Conventional PCRep     0 - 
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Last, I attempted simultaneous quadruple replacement by CRISPR-PCRep 
using two kinds of marker (CgLEU2 and CgHIS3).  For the set 1 regions, namely, Chr. 
3-2 (15 kb), Chr. 7-4 (19 kb ), Chr. 12-2 (14 kb), and Chr. 15-11 (26 kb), 360 Leu+ 
His+ transformants were obtained by CRISPR-PCRep, whereas none was obtained by 
conventional PCRep (Table 11).  Twelve transformants were randomly picked and 
analyzed for structural changes by colony PCR.  The data indicated that 10 
transformants (nos. 2 and 4-12) showed simultaneous double replacement, and 2 (nos. 
1 and 3) showed simultaneous triple replacement (Fig. 13A).  For example, double 
replacement was observed for the combinations of Chr. 3-2 (15 kb) and Chr. 15-11 
(26 kb), Chr. 12-2 (14 kb) and Chr. 15-11 (26 kb), and Chr. 3-2 (15 kb) and Chr. 7-4 
(19 kb); however, the combination of Chr. 7-4 (19 kb) and Chr. 12-2 (14 kb) was not 
observed.  Similarly, triple replacement was observed for the combination of Chr. 3-2 
(15 kb), Chr. 12-2 (14 kb), and Chr. 15-11 (26 kb); and Chr. 3-2 (15 kb), Chr. 7-4 (19 
kb), and Chr. 15-11 (26 kb); however, the combinations of Chr. 3-2 (15 kb), Chr. 7-4 
(19 kb), and Chr. 12-2 (14 kb); and Chr. 7-4 (19 kb), Chr. 12-2 (14 kb) and Chr. 15-11 
(26 kb) were not observed.  The colony PCR result of triple replacement were shown 
in Fig. 14. 
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Table 11. Transformants obtained in simultaneous quadruple replacements by CRISPR-PCRep. 
a Method: In this experiment, PCR fragment-based gRNA expression method was used in CRISPR-PCRep, and targeted chromos
modules.  Here, two selection markers were used for quadruple replacement. 
 
 
 
Replaced region (size) Methoda No. of 
transformants 
obtained 
No. of 
transformants 
analyzed by 
colony PCR 
No. (%) of 
transformants 
with double 
replacement  
No
trans
wit
repl
Chr. 3-2 (15 kb), Chr. 7-4 
(19 kb), Chr. 12-2 (14 kb), 
and Chr. 15-11 (26 kb) 
CRISPR-PCRep 360 12   10 (83)        2
Conventional 
PCRep 
    0 - - 
Chr. 3-2 (15 kb), Chr. 4-10 
(14 kb), Chr. 12-2 (14 kb), 
and Chr. 15-11 (26 kb) 
CRISPR-PCRep 355 10 10 (100)          
Conventional 
PCRep 
    0 - - 
Chr. 3-2 (15 kb), Chr. 4-10 
(14 kb), Chr. 9-5 (22 kb), 
and Chr. 7-4 (19 kb) 
CRISPR-PCRep 270   6   6 (100)          
Conventional 
PCRep 
    0 - - 
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Fig. 13.  Distribution of Leu+ His+ transformants in experiment for the attempt of simultaneous 
quadruple replacements by CRISPR-PCRep.  (A) Blue boxes represent deletion of the targeted 
chromosomal regions in the transformants obtained by the replacement experiment while white boxes 
represent presence of those regions in the transformants.  The combination of Chr. 3-2, Chr. 12-2, and 
Chr. 15-11 and Chr. 3-2, Chr. 7-4, and Chr. 15-11 region showed simultaneous triple replacement in 
transformant no. 1 and 3, respectively.  (B) Green boxes represent deletion of the targeted 
chromosomal regions in the transformants by replacement experiment while white boxes represent 
presence of those regions.  (C) Olive boxes represent deletion of the targeted chromosomal regions in 
the transformants by replacement experiment while white boxes represent presence of those regions.   
 
 
A 
B 
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Quadruple replacement by CRISPR-PCRep was performed for two other sets 
of chromosomal regions, resulting in 355 transformants for set 2 [Chr. 3-2 (15 kb), 
Chr. 4-10 (14 kb), Chr. 12-2 (14 kb), and Chr. 15-11 (26 kb)] and 270 transformants 
for set 3 [Chr. 3-2 (15 kb), Chr. 4-10 (14 kb), Chr. 7-4 (19 kb) and Chr. 9-5 (22 kb)] 
(Table 11).  Ten and six transformants from sets 2 and 3, respectively, were randomly 
picked and analyzed by colony PCR.  The results from set 2 showed simultaneous 
double deletion for the combination of Chr. 3-2 (15 kb) and Chr. 15-11 (26 kb); and 
Chr. 12-2 (14 kb) and Chr. 15-11 (26 kb) (Fig. 13B). The results from set 3 showed 
simultaneous double deletion for the combination of Chr. 3-2 (15 kb) and Chr. 7-4 (19 
kb) (Fig. 13C).  Taking all our observations together, I concluded that simultaneous 
triple replacement of internal chromosomal regions is possible by CRISPR-PCRep 
using two selection markers (Fig. 13 and 14).  
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Fig. 14.  Simultaneous replacement of four internal regions by CRISPR-PCRep.  (A) Scheme for 
simultaneous quadruple replacement of Chr. 3-2 (15 kb), Chr. 7-4 (19 kb), Chr. 12-2 (14 kb), and Chr. 
15-11 (26 kb) using the two selection markers CgLEU2 and CgHIS3.  Blue, pink, green, and orange 
boxes represent Chr. 3-2 (15 kb), Chr. 7-4 (19 kb), Chr. 12-2 (14 kb), and Chr. 15-11 (26 kb), 
respectively.  (B) Colony PCR for verification of simultaneous left-edge replacement  .  The DNA 
modules for Chr. 3-2 (15 kb), Chr. 12-2 (14 kb), and Chr. 7-4 (19 kb), Chr. 15-11 (26 kb) were marked 
with CgLEU2 and CgHIS3, respectively.  Appropriate primers were used to amplify 1200-bp (lanes 1-
4), 1100-bp (lanes 5-8), 1000-bp (lanes 9-12), and 900-bp (lanes 13-16) bands denoting the left edge of 
CgLEU2 and CgHIS3 in transformants.  The 670-bp CNE1 gene was also amplified as an internal 
control.  Among four transformants tested, transformant no. 1 (lanes 1, 5, 9, 13) showed the expected 
simultaneous left-edge replacement of Chr. 3-2 (15 kb), Chr. 12-2 (14 kb), and Chr. 15-11 (26 kb) in 
lanes 1, 9, and 13, respectively. Transformant no. 3 (lanes 3, 7, 11, 15) showed the expected 
simultaneous left-edge replacement of Chr. 3-2 (15 kb), Chr. 7-4 (19 kb), and Chr. 15-11 (26 kb) in 
lanes 3, 7, and 15.  (C) Colony PCR for verification of simultaneous right-edge replacement of the 
same chromosomal regions.  Appropriate primers were used to amplify 1200-bp (lanes 1-4), 1100-bp 
(lanes 5-8), 1000-bp (lanes 9-12), and 900-bp (lanes 13-16) bands denoting the right edge of CgLEU2 
and CgHIS3 in transformants.  Transformant nos. 1 (lanes 1, 9, 13) and 3 (lanes (3, 7, 15) showed the 
expected simultaneous right-edge replacement deletion of Chr. 3-2 (15 kb), Chr. 12-2 (14 kb), and Chr. 
15-11 (26 kb), respectively.  (D) Colony PCR for verification of simultaneous whole-region 
replacement of the same chromosomal regions.  Appropriate primers were used to amplify 2400-bp 
(lanes 1-4), 2200-bp (lanes 5-8), 2000-bp (lanes 9-12), and 1800-bp (lanes 13-16)  bands denoting the 
simultaneous presence of CgLEU2 and CgHIS3 in transformants.  Transformant nos.1 (lanes 1, 9, and 
13 ) and 3 (lanes 3, 7, and 15) showed simultaneous triple replacement. 
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3.4  Summary and conclusion of Chapter 3 
Genome manipulation, especially the deletion or replacement of chromosomal 
regions, is a salient tool for the analysis of genome function.  Because of low HR 
activity, however, current methods are limited to manipulating only one chromosomal 
region in a single transformation, making the simultaneous deletion or replacement of 
multiple chromosomal regions difficult, laborious, and time-consuming.  Here, I have 
developed two highly efficient and versatile genome engineering technologies, named 
CRISPR-PCD and CRISPR-PCRep, that integrate the CRISPR/Cas9 genome editing 
system into, respectively, the PCD method for chromosomal deletion and our newly 
developed PCRep method for chromosomal replacement.  Integration of CRISPR 
induces DSBs to activate HR, and thus enhances the efficiency of deletion by PCD 
and replacement by PCRep, enabling multiple chromosomal regions to be 
manipulated simultaneously for the first time.  Our data show that CRISPR-PCD can 
delete two internal or terminal chromosomal regions, while CRISPR-PCRep can 
replace triple chromosomal regions simultaneously in a single transformation. Colony 
PCR analysis of structural alterations showed that triple replacement of four different 
sets of chromosomal regions was successful in 83%–100% of transformants analyzed.  
These novel genome engineering technologies, which greatly reduce time and labor 
for genome manipulation, will provide powerful tools to facilitate the simultaneous 
multiple deletion and replacement of chromosomal regions, enabling the rapid 
analysis of genome function and breeding of useful industrial yeast strains. 
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Chapter 4 
General Discussion and Conclusion 
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The last three decades have witnessed a great development in the field of yeast 
genome engineering.  Since the pioneering work in the 1980s on native HR, several 
new methods and techniques have been introduced i.e., error-free DNA repair 
mechanism for genome manipulation (Ma et al., 1987).  This has been particularly 
important for yeast strains used for industrial purposes for which an increase in the 
production of useful metabolites or elimination of others was desired but also for 
researchers who use S. cerevisiae as a model organism.  For several years, gene 
knock-out has been carried out by introducing a linear double-stranded deletion 
cassette containing a marker flanked with complementary regions to the target locus.  
Although this method is still widely used, new methods of precise genome 
engineering continue to emerge.   
In this study, to simplify the expression of gRNA in the S. cerevisiae host 
(diploid strain SJY347), I developed a system based on only PCR without plasmid-
based cloning.  My basic idea was to develop a simple gRNA expression system that 
expresses gRNA from a PCR fragment (called “fragment C”, Fig. 3) since plasmid 
construction for expressing gRNA is laborious and time-consuming.  Fragment C 
comprised the SNR52 promoter, targeted genome sequence as a guiding sequence, and 
gRNA scaffold, and was prepared by simple overlap PCR using fragments A and B.  
This PCR-based method for delivering gRNA in the CRISPR/Cas9 system of genome 
editing was called gRNA-TES.  Including the transformation process gRNA-TES can 
be completed within 5–6 hours, whereas conventional a plasmid-based method 
requires at least 3–4 days to construct and verify the plasmid that delivers gRNA.  
Moreover, I have evaluated the performance of gRNA-TES in terms of following 
parameters i) the number of transformants, ii) frequency (percentage) of transformants 
with expected replacement, and iii) efficient replacement of very long target regions 
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of the genome (<500 kb) by a small sized DNA module.  All result demonstrated that 
a high frequency of transformants with the expected replacement were obtained with 
gRNA-TES as compared with transformation without gRNA-TES.  In addition to the 
simplicity of the methodology, gRNA-TES has another advantage.  In previous 
CRISPR/Cas9 systems, gRNA is expressed continuously from an autonomously 
replicating plasmid, meaning that the target is continuously attacked by Cas9 because 
the autonomously replicating plasmid continues to deliver gRNA during mitotic 
growth.  In gRNA-TES, by contrast, gRNA is transiently expressed and likely to be 
gradually lost during colony formation because it is supplied from a non-replicating 
PCR fragment (fragment C).   This situation may contribute to increasing numbers of 
transformants in cases where the target sequence remains present after the desired 
genome manipulation has been completed, for example, in applications of PCDup 
technology (Natesuntorn et al., 2015) in which the target site remains in the intact 
chromosome.   
During this study, I noted that some of the DNA polymerases produced 
multiple unexpected bands in PCR.  Therefore, to refine gRNA-TES and also make it 
more user-friendly, different kinds of DNA polymerase were tested in the PCR steps.  
Except for Ex Taq DNA polymerase, DNA polymerases including KOD Plus Neo, 
KOD Fx, KOD Fx Neo, and Prime STAR HS were found to frequently produce 
multiple unexpected bands, especially during the overlap PCR used to prepare 
fragment C (data not shown).  Although the reason for this is not known at present, I 
recommend using Ex Taq DNA polymerase for gRNA-TES.  To assess the structural 
changes of chromosomes in transformants, I adopted a modified colony PCR method 
in which genomic DNA was prepared within 15 minutes (NaOH protocol) and I used 
PrimeSTAR Max Premix (2x), which requires an extension time of only 5 sec/kb 
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colony PCR.  By employing these modifications, the analysis of chromosomal 
structural alteration was also completed in a very short time i.e., about 1 hour and 30 
minutes.  gRNA-TES enabled the replacement of a very long chromosomal region of 
up to 500 kb (Fig. 4C) with a frequency of 100%.  In addition, replacement of the 
desired target region of one chromosome occurred without causing structural changes 
to the homologous chromosome (Fig. 5H and I).  These observations suggest that 
gRNA-TES can be used to effectively obtain transformants harboring replacement of 
a desired targeted region of one of homologous chromosomes without triggering 
unexpected structural alterations of the other homologous chromosome in a diploid 
host.  
I occasionally obtained a transformant with only left or right edge replacement.  
For example, among six transformants tested for replacement of the Chr4-200 region, 
one did not show the expected 1000-bp band in the analysis of left edge replacement 
but showed in the analysis of the expected band in right edge replacement (Fig. 5B, 
lane 7).  It is possible that HR occurred only at the right edge of the target region, 
while irregular (or illegitimate) recombination with the DNA module might have 
occurred at the left edge.  However, this event was observed infrequently among the 
transformants.  Taking all observations together, I will say that gRNA-TES provides a 
simple, fast, cost-effective and highly efficient tool for genome engineering, and is 
likely to make CRISPR/Cas9 technology accessible to more biologists and 
biotechnologists. 
Next, in the later part of this study, I developed other two new genome 
engineering technologies, which is called CRISPR-PCD and CRISPR-PCRep, by 
integrating the CRISPR/Cas9 systems into PCD and PCRep.  Both technologies 
provided highly efficient tools for the deletion or replacement of multiple 
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chromosomal regions simultaneously in a one-step transformation.  Simultaneous 
double deletion of chromosomal regions using conventional PCD was unsuccessful 
previously; therefore, the successful segmental chromosomal deletion or replacement 
of multiple chromosomal regions by CRISPR-PCD or CRISPR-PCRep method is 
probably a consequence of the DSBs induced by CRISPR/Cas9 that increase the 
frequency of HR.  This idea is supported by the fact that the deletion efficiency of a 
single chromosomal region was increased approximately 228-fold by CRISPR-PCD 
(Table 7) relative to conventional PCD.  This marked increase in deletion efficiency is 
probably the reason for the successful deletion of multiple chromosomal regions.  In 
fact, I succeeded in obtaining up to three simultaneous deletions with 83%–100% 
frequency via a replacement experiment using three selection markers and CRISPR-
PCRep (Table 10 and Fig. 12).  I also obtained the simultaneous replacement of three 
chromosomal regions by using two selection markers (Table 11 and Fig. 13, 14).  
Two transformants showed simultaneous triple replacement for the combination of 
Chr. 3-2 (15 kb), Chr. 12-2 (14 kb), and Chr. 15-11 (26 kb); and Chr. 3-2 (15 kb), Chr. 
7-4 (19 kb), and Chr. 15-11 (26 kb), although the quadruple replacement of Chr. 3-2 
(15 kb), Chr. 7-4 (19 kb), Chr. 12-2 (14 kb), and Chr. 15-11 (26 kb) was not observed.  
A possible reason for not obtaining simultaneous quadruple replacement may not be 
clear at this moment.  It might be due to synthetic lethality.  This possibility will be 
investigated in a future study.  Nevertheless, I will say that it is possible to perform 
triple replacement simultaneously using two selection markers (partly marker-free) in 
a one-step transformation.  In the triple replacement experiment, nine types of DNA 
fragments (i.e., six PCR fragments expressing gRNA and three DNA modules for 
replacement) were introduced together in a single transformation.  Previously, Gibson 
et al. reported that S. cerevisiae can take up 25 different DNA fragments in an 
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experiment to construct the synthetic genome of Mycoplasma genitalium (Gibson et 
al., 2008).  This suggests that once a yeast cell acquires competency, it is able to take 
up multiple kinds of foreign DNA.  Therefore, if multiple foreign DNA fragments are 
introduced together, multiple targets will be manipulated simultaneously by CRISPR-
PCD or CRISPR-PCRep.  On the basis of this observation, simultaneous 
replacement/deletion of more chromosomal regions, possibly up to eight (i.e., 8 donor 
DNA modules and 16 PCR fragments expressing gRNA), might be possible using 
CRISPR-PCRep.  In conventional PCD, an experiment for a single deletion takes at 
least 11 days (including 6 days for verification by PFGE followed by Southern blot 
analysis).  Therefore, if the deletion of multiple chromosomal regions is conducted 
sequentially by conventional PCD, it will take 22, 33, and 44 days for the respective 
deletion of two, three, and four chromosomal regions.  By contrast, the CRISPR-
PCRep and CRISPR-PCD methods described in this study will take only 7 and 11 
days for simultaneous multiple chromosomal replacement and deletion, respectively.  
This considerable reduction in experimental time for generating multiple deletions 
and replacements greatly enhances the usability and applicability of CRISPR-PCRep 
and CRISPR-PCD for genome engineering.   
In conclusion, based upon the data presented in this study, I successfully 
developed three methods i.e., gRNA-TES for simple gRNA expression, CRISPR-
PCD and CRISPR-PCRep for simultaneous multiple segmental chromosomal deletion 
and replacement which are novel genome engineering methods that offer a more rapid 
means for manipulating multiple chromosomal regions both for breeding and for 
investigating genome function in yeast.  In addition, it should be emphasized that 
these powerful technologies are applicable to not only yeasts, but also a broad range 
of organisms. 
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Supplementary Tables 
 
Table S1. Primers used for generating DNA modules. 
Primer 
name 
Chromosome number 
(coordinates) 
Nucleotide sequence (5’-3’) 
SJP173 Chr4 (494241-494270) Fw TGCTCTTAAGGTTTGACACGCTGTCCA
TTCGGCCGCCAGCTGAAGCTTCG 
SJP340 Chr4 (644271-644300) Rv TTTTCTGAATGGCCAACTTTCCCTCAAC
TTAGGCCACTAGTGGATCTGAT 
SJP341 Chr4 (694271-694300) Rv TTCCCCGGCTTGCAAATAACGACGATG
AGT AGGCCACTAGTGGATCTGAT 
SJP352 Chr4 (794271-794300) Rv TCTTTATCCTTCTCATGTTCATCTCCAC
ACAGGCCACTAGTGGATCTGAT 
SJP353 Chr4 (894271-894300) Rv ATCATTCTAGCATGTTCCGCATGTTCCT
TGAGGCCACTAGTGGATCTGAT 
SJP354 Chr4 (994271-994300) Rv CCTCTATTTATATGACCTCACCAGCAGC
GAAGGCCACTAGTGGATCTGAT 
 
 
Table S2. Primers used for generating fragments A, B, and C. 
Primer 
name 
Chromosome number 
(coordinates) 
Nucleotide sequence (5’-3’) 
SJP115 Plasmid p426 (5001-5020) Rv ACTCACAAATTAGAGCTTCA 
SJP117 Plasmid p426 (3855-3884) Rv TTTATCTTTCACTGCGGAGAAGTTTCGAAC 
SJP120 Plasmid p426 (3301-3320) Fw CGAACGACCGAGCGCAGCGA 
SJP180 Chr4 (494276-494295) Fw GTTCGAAACTTCTCCGCAGTGAAAGATAA 
ATGATCTGCGTCAAGAAGAAAGATAAGTTTT
AGAGCTAGAAATAGCAAG 
SJP342 
 
Chr4 (644251-644270) Fw GTTCGAAACTTCTCCGCAGTGAAAGATAA 
ATGATCTATATAAATGGGGAGTTTCAGTTT 
88 
 
TAGAGCTAGAAATAGCAAG 
SJP343 
 
Chr4 (694244-694263) Fw GTTCGAAACTTCTCCGCAGTGAAAGATAA 
ATGATCATTATGTATGTAGGTAATAAGTTT 
TAGAGCTAGAAATAGCAAG 
SJP355 
 
Chr4 (794235-794254) Fw GTTCGAAACTTCTCCGCAGTGAAAGATAA 
ATGATCTGTATCTTTATATTATAGCGGTTT 
TAGAGCTAGAAATAGCAAG 
SJP356 
 
Chr4 (894243-894262) Fw GTTCGAAACTTCTCCGCAGTGAAAGATAA 
ATGATCGTCATCCTTGCCGTCGCCTCGTTT 
TAGAGCTAGAAATAGCAAG 
SJP357 
 
Chr4 (994239-994258) Fw GTTCGAAACTTCTCCGCAGTGAAAGATAA 
ATGATCCACTTAGAAAATTGATGGTAGTTT 
TAGAGCTAGAAATAGCAAG 
 
 
 
Table S3. Primers used for colony PCR. 
Primer  
name 
Chromosome number 
(coordinates) 
Nucleotide sequence (5’-3’) 
SJP119 CgLEU2 (776-800) Rv CCCACTAGTTCTCTAACAACGACGA 
SJP121 CNE1 (211-230) Fw TCACAGGGTCGATTGCAAGG 
SJP127 CgLEU2 (776-800) Fw TCGTCGTTGTTAGAGAACTAGTGGG 
SJP238 Chr4 (494071-494095) Fw CATATCAGTGTCTTCATCTTCATGA 
SJP242 CNE1 (880-861) Rv CTGGTGGTTCAGTGCCATCT 
SJP245 Chr4 (495546-495570) Rv TAAAAGTCCAAACGAAAACCAGCAC 
SJP350 Chr4 (644336-644360) Rv GTAAGATTTGGCTTCTTTGATATAT 
SJP351 Chr4 (694336-694360) Rv GTTCCACCAATATCAACTTCTTGTC 
SJP364 Chr4 (794336-794360) Rv CTGAGAGGGTAGAGGCGCCTTCCTT 
SJP365 Chr4 (894336-894360) Rv CATTGAGCTTTACTGCACGTTCCCG 
SJP366 Chr4 (994336-994360) Rv TAGTGGATACGCAGGACGTGTTATC 
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Table S4. gRNA target sequence for plasmid-based gRNA expression. 
Deleted region Target sequence (5’-3’) Chromosome (position)a 
Chr. 8-L 
 
Chr. 11-L 
 
Chr. 9-5L 
 
Chr. 9-5R 
 
Chr. 15-8L 
 
Chr. 15-8R 
 
Chr. 15-11L 
 
Chr. 15-11R 
 
GATGAAGTCATGAATTTGCA 
 
GACATCCATACTGTTGCTGC 
 
GAAGGGCAATTGTACGTTTC 
 
ATTCTTGCTCCTTTTTACTC 
 
ATATAGCTTGTTCTCTCTAA 
 
TTAAGTGGCGAAACATCTTC 
 
ATGATGTATTGTCATACTGA 
 
AACTACGCGCAGTTTGAAAG 
 
Chr. 8 (22165.5) 
 
Chr. 11 (29602.5)  
 
Chr. 9 (321446.5)  
 
Chr. 9 (343693.5)  
 
Chr. 15 (476145.5)  
 
Chr. 15 (500182.5)  
 
Chr. 15 (969017.5)  
 
Chr. 15 (994994.5)  
a Target sequence expressed as a part of gRNA in host cell.
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Table S5. Primers for the construction of gRNA expression plasmid, gRNA expressing fragment, PC
for karyotype analysis. 
Name of primers  Nucleotide sequence (5’-3’) 
 
For gRNA expression plasmid construction 
 
Chr. 8-L-lp-gRNA-Fw 
 
Chr. 8-L-lp-gRNA-Rv 
 
Chr. 11-L-lp-gRNA-Fw 
 
Chr. 11-L-lp-gRNA-Rv 
 
Chr. 9-5-lp-gRNA-Fw 
 
Chr. 9-5-lp-gRNA-Rv 
 
Chr. 9-5-rp-gRNA-Fw 
 
Chr. 9-5-rp-gRNA-Rv 
 
Chr. 15-8-lp-gRNA-Fw 
 
Chr. 15-8-lp-gRNA-Rv 
 
Chr. 15-8-rp-gRNA-Fw 
 
 
 
 
GATGAAGTCATGAATTTGCAGTTTTAGAGC
 
TGCAAATTCATGACTTCATCGATCATTTAT
 
GACATCCATACTGTTGCTGCGTTTTAGAGC
 
GCAGCAACAGTATGGATGTCGATCATTTAT
 
GAAGGGCAATTGTACGTTTCGTTTTAGAGC
 
GAAACGTACAATTGCCCTTCGATCATTTAT
 
ATTCTTGCTCCTTTTTACTCGTTTTAGAGCT
 
GAGTAAAAAGGAGCAAGAATGATCATTTA
 
ATATAGCTTGTTCTCTCTAAGTTTTAGAGC
 
TTAGAGAGAACAAGCTATATGATCATTTAT
 
TTAAGTGGCGAAACATCTTCGTTTTAGAGC
 
GAAGATGTTTCGCCACTTAAGATCATTTAT
91 
 
 
 
Chr. 15-8-rp-gRNA-Rv 
 
Chr. 15-11-lp-gRNA-Fw 
 
Chr. 15-11-lp-gRNA-Rv 
 
Chr. 15-11-rp-gRNA-Fw 
 
Chr. 15-11-rp-gRNA-Rv 
 
ATGATGTATTGTCATACTGAGTTTTAGAGC
 
TCAGTATGACAATACATCATGATCATTTAT
 
AACTACGCGCAGTTTGAAAGGTTTTAGAGC
 
CTTTCAAACTGCGCGTAGTTGATCATTTAT
 
 
For generating gRNA expressing PCR fragments 
 
Plasmid p426 (3301-3320) Fw 
 
Plasmid p426 (3855-3884) Rv 
 
Plasmid p426 (5001-5020) Rv 
 
Chr. 3-2 gRNA left Fw 
 
 
Chr. 3-2 gRNA right Fw 
 
 
Chr. 4-4 gRNA left Fw 
 
 
Chr. 4-4 gRNA right Fw 
 
 
 
 
CGAACGACCGAGCGCAGCGA 
 
TTTATCTTTCACTGCGGAGAAGTTTCGAAC
 
ACTCACAAATTAGAGCTTCA 
 
GTTCGAAACTTCTCCGCAGTGAAAGATAAA
GTGTTTTAGAGCTAGAAATAGCAAG 
 
GTTCGAAACTTCTCCGCAGTGAAAGATAAA
CAGTTTTAGAGCTAGAAATAGCAAG 
 
GTTCGAAACTTCTCCGCAGTGAAAGATAAA
CTGTTTTAGAGCTAGAAATAGCAAG 
 
GTTCGAAACTTCTCCGCAGTGAAAGATAAA
TTGTTTTAGAGCTAGAAATAGCAAG 
92 
 
 
 
 
Chr. 4-10 gRNA left Fw 
 
 
Chr. 4-10 gRNA right Fw 
 
 
Chr. 5-3 gRNA left Fw 
 
 
Chr. 5-3 gRNA right Fw 
 
 
Chr. 7-4 gRNA left Fw 
 
 
Chr. 7-4 gRNA right Fw 
 
 
Chr. 9-5 gRNA left Fw 
 
 
Chr. 9-5 gRNA right Fw 
 
 
Chr. 10-4 gRNA left Fw 
 
 
Chr. 10-4 gRNA right Fw 
 
GTTCGAAACTTCTCCGCAGTGAAAGATAAA
CGTTTTAGAGCTAGAAATAGCAAG 
 
GTTCGAAACTTCTCCGCAGTGAAAGATAAA
TGTTTTAGAGCTAGAAATAGCAAG 
 
GTTCGAAACTTCTCCGCAGTGAAAGATAAA
GTGTTTTAGAGCTAGAAATAGCAAG 
 
GTTCGAAACTTCTCCGCAGTGAAAGATAAA
GTGTTTTAGAGCTAGAAATAGCAAG 
 
GTTCGAAACTTCTCCGCAGTGAAAGATAAA
CTGTTTTAGAGCTAGAAATAGCAAG 
 
GTTCGAAACTTCTCCGCAGTGAAAGATAAA
CGGTTTTAGAGCTAGAAATAGCAAG 
 
GTTCGAAACTTCTCCGCAGTGAAAGATAAA
AAGTTTTAGAGCTAGAAATAGCAAG 
 
GTTCGAAACTTCTCCGCAGTGAAAGATAAA
AAGTTTTAGAGCTAGAAATAGCAAG 
 
GTTCGAAACTTCTCCGCAGTGAAAGATAAA
AGGTTTTAGAGCTAGAAATAG AAG 
 
GTTCGAAACTTCTCCGCAGTGAAAGATAAA
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Chr. 12-2 gRNA left Fw 
 
 
Chr. 12-2 gRNA right Fw 
 
 
Chr. 15-11 gRNA left Fw 
 
 
Chr. 15-11 gRNA right Fw 
GCGTTTTAGAGCTAGAAATAGCAAG 
 
GTTCGAAACTTCTCCGCAGTGAAAGATAAA
CCGTTTTAGAGCTAGAAATAGCAAG 
 
GTTCGAAACTTCTCCGCAGTGAAAGATAAA
AAGTTTTAGAGCTAGAAATAGCAAG 
 
GTTCGAAACTTCTCCGCAGTGAAAGATAAA
AGTTTTAGAGCTAGAAATAGCAAG 
 
GTTCGAAACTTCTCCGCAGTGAAAGATAAA
AGGTTTTAGAGCTAGAAATAGCAAG 
 
For construction of deletion module 
 
CA primer (Rv) 
 
 
Chr. 8-L Fw 
 
 
Chr. 11-L Fw 
 
 
Chr. 9-5L Fw 
 
 
Chr. 9-5R Fw 
 
 
 
CCCCAACCCCAACCCCAACCCCAACCCCAA
GAT 
 
GCTTGGAACAGCATCCTCCACTCCTTTACT
GCCAGCTGAAGCTTCG 
 
GAGGAACATCTGGAGGTTAGAACATGTTT
CGCCAGCTGAAGCTTCG 
 
CTGTAGTGCTGGTTTCAATCCTGTTTGTTGG
CGCCAGCTGAAGCTTCG 
 
AAGGGAAAAAAAATGTTCAGCATTGAGAG
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Chr. 15-8L Fw 
 
 
Chr. 15-8R Fw 
 
 
Chr. 15-11L Fw 
 
 
Chr. 15-11R Fw 
 
CCGCCAGCTGAAGCTTCG 
 
TCAGTAAGTTTTTGCAATTGTTAAAATTTT
GCCAGCTGAAGCTTCG 
 
GCAGAAAGCACTAAGGCTATTGATATTTCG
CGCCAGCTGAAGCTTCG 
 
TACTTATTAACGTACTCAAACAACTACACT
GCCAGCTGAAGCTTCG 
 
CATTTCTCAGGCAATACCGAAAAAGAAGA
CGCCAGCTGAAGCTTCG 
 
For construction of donor DNA module 
 
Chr. 3-2 Mod Fw 
 
 
Chr. 3-2 Mod Rv 
 
 
Chr. 4-4 Mod Fw 
 
 
Chr. 4-4 Mod Rv 
 
 
Chr. 4-10 Mod Fw 
 
 
 
TTATGCATTTTCAATTGTTCGCGTTCTTTAG
GCCAGCTGAAGCTTCG 
 
ACATGTCAGACGTTATAACCGGACTGCGCA
CCACTAGTGGATCTGAT    
 
AAGTTGACCAATAAGTCCTTCAAGTTTTGG
CGCCAGCTGAAGCTTCG 
 
AGATTAACAAGAGAGAGAAGTTCTACGCA
GCCACTAGTGGATCTGAT 
 
CTTCATCCTTAAAGTTGGCACCAATACCAA
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Chr. 4-10 Mod Rv 
 
 
Chr. 5-3 Mod Fw 
 
 
Chr. 5-3 Mod Rv 
 
 
Chr. 7-4 Mod Fw 
 
 
Chr. 7-4 Mod Rv 
 
 
Chr. 9-5 Mod Fw 
 
 
Chr. 9-5 Mod Rv 
 
 
Chr. 10-4 Mod Fw 
 
 
Chr. 10-4 Mod Rv 
 
 
CGCCAGCTGAAGCTTCG 
 
AGAAGTGCCTCAGCAAGTAAAAGGTGGAG
CCACTAGTGGATCTGAT 
 
AGGCCTACTATTGACTGCTTTTTCTGCAAA
GCCAGCTGAAGCTTCG 
 
AACGAACTTTAAACGTAAAAAATAAGAAA
GCCACTAGTGGATCTGAT 
 
AGTTTAACGATCGGCTTTGCTGTTAAGTGG
GCCAGCTGAAGCTTCG 
 
CTTCAATTAGCGTGATACTTAGGCTTCATT
CACTAGTGGATCTGAT 
 
CTGTAGTGCTGGTTTCAATCCTGTTTGTTGG
GCCAGCTGAAGCTTCG 
 
AAGGGAAAAAAAATGTTCAGCATTGAGAG
GCCACTAGTGGATCTGAT 
 
AAAATATGTCGGTATAGCCTACTCGAGACG
CGCCAGCTGAAGCTTCG 
 
ATTTTCCCGGTGTCGGTAATGCTATTGATG
CACTAGTGGATCTGAT 
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Chr. 12-2 Mod Fw 
 
 
Chr. 12-2 Mod Rv 
 
 
Chr. 15-11 Mod Fw 
 
 
Chr. 15-11 Mod Rv 
ACCGCCGCAGACTGCCATATTATTGCACTA
CGCCAGCTGAAGCTTCG 
 
TTTGAAAGAACCGAACCGATGCCAAAATC
CCACTAGTGGATCTGAT 
 
TACTTATTAACGTACTCAAACAACTACACT
GCCAGCTGAAGCTTCG 
 
CATTTCTCAGGCAATACCGAAAAAGAAGA
CCACTAGTGGATCTGAT 
 
For colony PCR and karyotype analysis 
 
CNE1 (211-230) Fw 
 
CNE1 (880-861) Rv 
 
CgLEU2 (776-800) Fw 
 
CgLEU2 (776-800) Rv 
 
CgHIS3 (401-425) Fw 
 
CgHIS3 (401-425) Rv 
 
URA3 (116545-116569) Fw 
 
URA3 (116545-116569) Rv 
 
 
 
TCACAGGGTCGATTGCAAGG 
 
CTGGTGGTTCAGTGCCATCT 
 
TCGTCGTTGTTAGAGAACTAGTGGG 
 
CCCACTAGTTCTCTAACAACGACGA 
 
GCTGGGCCAAGCGTTCAAGGAGGCG 
 
CGCCT CCTTGAACGCTTGGCCCAGC 
 
CCAGGTATTGTTAGCGGTTTGAAGC 
 
GCTTCAAACCGCTAACAATACCTGG 
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Chr. 3-2 D./Q. colony Fw 
 
Chr. 3-2 D./Q. colony Rv 
 
Chr. 4-4 D. colony Fw 
 
Chr. 4-4 D. colony Rv 
 
Chr. 4-10 D. colony Fw 
 
Chr. 4-10 D. colony Rv 
 
Chr. 5-3 D. colony Fw 
 
Chr. 5-3 D. colony Rv 
 
Chr. 7-4 D./Q. colony Fw 
 
Chr. 7-4 D. colony Rv 
 
Chr. 9-5 D./Q. colony Fw 
 
Chr. 9-5 D./Q. colony Rv 
 
Chr. 10-4 D. colony Fw 
 
Chr. 10-4 D. colony Rv 
 
 
TGTGCTTGAGCCTGTTCCAACTGTT 
 
ACAGAGTCACTTGAGTGGTTGGATT 
 
GTGCGGCACTTCTAATCAAATAAAC 
 
GTCATGGCCTCTTACTGGTGGTGGG 
 
TTTAGGGTGGCGTTAAATAAACGAG 
 
CTACAATAAGAAACACGATTTGAGA 
 
CTATTGTAATTAGCTGCAATCATCT 
 
CGGCGGAAAAGGAGGAAGACAGGCC 
 
GTGTACGATGGCCTAGGGAACAAGA 
 
ATATATCTATAGATTTGCCTATTGG 
 
ATGGACTTGAAGGAGAGCCATAGCT 
 
GATAAGGCTTACTTTATAACGGTTG 
 
CCTCCTTTTTATCTGTGAATGACAG 
 
CCTAATATTCTTGAAAGTTATAGCG 
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Chr. 12-2 D./Q. colony Fw 
 
Chr. 12-2 D./Q. colony Rv 
 
Chr. 15-11 D./Q. colony Fw 
 
Chr. 15-11 D. colony Rv 
 
Chr. 3-2 T./Q. colony Fw 
 
Chr. 3-2 T./Q. colony Rv 
 
Chr. 4-10 T. colony Fw 
 
Chr. 4-10 T. colony Rv 
 
Chr. 7-4 T. colony Fw 
 
Chr. 7-4 T. colony Rv 
 
Chr. 9-5 T. colony Fw 
 
Chr. 9-5 T. colony Rv 
 
Chr. 12-2 T./Q. colony Fw 
 
Chr. 12-2 T./Q. colony Rv 
 
Chr. 15-11 T. colony Fw 
GGAAACCATATCAAATGTCAGGGTT 
 
GTTATTAAGGTATGTGCAGTTGATT 
 
GGATTTGGTTTTGATACATACTGCA 
 
TAAATTCAGACTGGAAAAGGAAGTT 
 
AATTAATTAACTAATTTACCGGAGT 
 
TATTCGGTTTGCATCTTGGCAAGCC 
 
TCTATTTATTAAAAGGTTTTAAAAA 
 
TATGCATTCAAATGTAGATTCAGCT 
 
TGTAACAAAATGAAAAAAAAAAAAA 
 
AGGAAAAAAGAAAACTGGCAATGTA 
 
AAAAATATCGCGAACTGACATAACC 
 
CATTAATTCTCGAAATTTGCTGTCC 
 
AATGCGTAGAAGCCGGGAATGGGAC 
 
GCGCCAGAAGTTTCACGGATGTGCT 
 
GTTCTTGGTTTTTTTTAAAGGTGTG 
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Chr. 15-11 T. colony Rv 
 
Chr. 4-10 Q. colony Fw 
 
Chr. 4-10 Q. colony Rv 
 
Chr. 7-4 Q. colony S1 Fw 
 
Chr. 7-4 Q. colony S1 Rv 
 
Chr. 7-4 Q. colony S3 Rv 
 
Chr. 15-11 Q. colony Rv 
 
Chr. 8-L colony Fw 
 
Chr. 8-L colony Rv 
 
Chr. 9-5 colony Fw 
 
Chr. 9-5 colony Rv 
 
Chr. 11-L colony Fw 
 
Chr. 11-L colony Rv 
 
Chr. 15-11 colony Fw 
 
 
GCAATAACGAAGGCCCTAAACTAGA 
 
ATTTTGTGCT TATGAAAAAA TTAGT 
 
GGTCTCCAAA GGTTTTAGAA TATTG 
 
ATAATTATCT TATCTTTTAC TTACA 
 
CTATATGAAT TCGTGGCACT TTTTG 
 
CTTCAATTAG CGTGATACTT AGGCT 
 
CATTTCTCAG GCAATACCGA AAAAG 
 
TGCGAAGGTGAGACAGTGAT 
 
TCAAACTGTGACCCCCATCT 
 
TTAACAAACGATGGCACTGG 
 
ACCTTCATAGCCCTTAACGGA 
 
GCCAATGACACGACGTTCTG 
 
CCTGGGTATTTGCCTGGATC 
 
ACAACAAGGCGTCCAAGAAC 
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Chr. 15-11 colony Rv 
 
Chr. 8-L probe Fw 
 
Chr. 8-L probe Rv 
 
Chr. 11-L probe Fw 
 
Chr. 11-L probe Rv 
TGCATCGCGTACCTGAGATT 
 
TGGATGGTGCATTCTTAGAG 
 
TGGGTAAGGAAATGAGAGCA 
 
CTAATTCAGCGTCAAGAGCT 
 
CCACTAGACGTTTCTGACTA 
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Table S6. Deleted regions, size, and plasmids used in CRISPR-PCD/CRISPR-PCRep. 
Deleted region Size of deleted region  
Single deletion by CRISPR-PCD 
 
Chr. 8-L 1 - 22193 (22 kb) 
Chr. 11-L 1 - 29638 (30 kb) 
Chr. 15-8 476081 - 500182 (24 kb) 
Chr. 15-11 969010 - 995010 (26 kb) 
Double deletion by CRISPR-PCD 
 
Chr. 8-L/Chr. 11-L 1 - 22193 (22 kb)/1 - 29638 (30 kb) 
Chr. 9-5/Chr. 15-11 321433 - 343693 (22 kb)/969010 - 995010 (26 kb)
Double replacement by CRISPR-PCRep 
 
 
Chr. 3-2/Chr. 7-4 68950 -83624 (15 kb)/190867 - 210017 (19 kb) 
Chr. 7-4/Chr. 12-2 190867 - 210017 (19 kb)/782360 - 796254 (14 kb)
Chr. 4-10/Chr. 12-2 1473549 - 1487620 (14 kb)/782360 - 796254 (14 k
Chr. 3-2/Chr. 5-3 68950 - 83624 (15 kb)/126605 - 141203 (15 kb) 
Chr. 4-4/Chr. 5-3 309991 - 334228 (24 kb)/126605 - 141203 (15 kb)
Triple replacement by CRISPR-PCRep 
 
Chr. 3-2/Chr. 4-10/Chr. 9-5  68950 - 83624 (15 kb)/1473549 - 1487620 (14 kb)
321433 - 343693 (22 kb) 
Chr. 4-10/Chr. 7-4/Chr. 12-2 1473549 - 1487620 (14 kb)/190867 - 210017 (19 k
782360 - 796254 (14 kb)  
Chr. 3-2/Chr. 7-4/Chr. 15-11 68950 - 83624 (15 kb)/190867 - 210017 (19 kb)/  
969010 - 995010 (26 kb) 
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a Plasmids used as template to prepare modules. 
 
 
 
Chr. 3-2/Chr. 4-10/Chr. 7-4  68950 - 83624 (15 kb)/1473549 - 1487620 (14 kb)
190867 - 210017 (19 kb) 
Quadruple replacement by CRISPR-PCRep 
 
 
 
Chr. 3-2/Chr. 7-4/Chr. 12-2/Chr. 15-11 68950 - 83624 (15 kb)/190867 - 210017 (19 kb)/  
782360 - 796254 (14 kb)/969010 - 995010 (26 kb)
Chr. 3-2/Chr. 4-10/Chr. 12-2/Chr. 15-11 68950 - 83624 (15 kb)/1473549 - 1487620 (14 kb)
782360 - 796254 (14 kb)/969010 - 995010 (26 kb)
Chr. 3-2/Chr. 4-10/Chr. 7-4/Chr. 9-5 68950 - 83624 (15 kb)/1473549 - 1487620 (14 kb)
190867 - 210017 (19 kb)/321433 - 343693 (22 kb)
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